BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Benedict M, Zhang X. Non-alcoholic fatty liver disease: An expanded review. World J Hepatol 2017; 9(16): 715-732 [PMID: 28652891 DOI: 10.4254/wjh.v9.i16.715]
URL: https://www.wjgnet.com/1948-5182/full/v9/i16/715.htm
Number Citing Articles
1
Hao Qin, Baowen Yuan, Wei Huang, Yan Wang. Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent AdvancesFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.924696
2
M. Zhao, Y. Hu, C. Shi, K. Wang, J. Li, J. Song, C. Huo, Y. Xi, S. Bu, Q. Huang. NFI, a clinical scoring tool for predicting non-alcoholic fatty liver in the Chinese populationPublic Health 2022; 202: 12 doi: 10.1016/j.puhe.2021.10.012
3
Guillermo Nahúm López-Sánchez, Mayra Dóminguez-Pérez, Misael Uribe, Norberto Carlos Chávez-Tapia, Natalia Nuño-Lámbarri. Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the diseaseAnnals of Hepatology 2021; 21: 100212 doi: 10.1016/j.aohep.2020.04.012
4
M.S. Abdelbary, R. Marzaban, H. Gamal Eldeen, M. Khairy, M. Menesy, M.H. Fahmy, A.M. Ayad, B.S. Mouheb, A. Yosry. La utilidad clínica de la elastografía transitoria como una herramienta de imagenología para evaluar el impacto a corto plazo de la gastrectomía laparoscópica en manga, en conjunto con parámetros clínicos y bioquímicos e índices clínico-bioquímicos en pacientes con enfermedad de hígado graso no alcohólico: un estudio piloto egipcioRevista de Gastroenterología de México 2021; 86(2): 125 doi: 10.1016/j.rgmx.2020.04.007
5
Avica Atri, Stephen A Jiwanmall, Munaf B Nandyal, Dheeraj Kattula, Sandhiya Paravathareddy, Thomas V Paul, Nihal Thomas, Nitin Kapoor. The Prevalence and Predictors of Non-alcoholic Fatty Liver Disease in Morbidly Obese Women – A Cross-sectional Study from Southern IndiaEuropean Endocrinology 2020; 16(2): 152 doi: 10.17925/EE.2020.16.2.152
6
I. O. Khramtsova, M. A. Derbak, T. M. Ganich, V. V. Svistak, O. T. Ganich. FREQUENCY OF THE LIVER INJURY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ACCORDING TO THE RESULTS OF NON-INVASIVE METHODS OF RESEARCH Bulletin of Problems Biology and Medicine 2021; 3(1): 153 doi: 10.29254/2077-4214-2021-3-161-153-157
7
Yaoxiang Zhu, Ruijue Liu, Zhenglin Shen, Guoqiang Cai. Combination of luteolin and lycopene effectively protect against the “two-hit” in NAFLD through Sirt1/AMPK signal pathwayLife Sciences 2020; 256: 117990 doi: 10.1016/j.lfs.2020.117990
8
Panyavee Pitisuttithum, Wah Kheong Chan, Panida Piyachaturawat, Kento Imajo, Atsushi Nakajima, Yosuke Seki, Kazunori Kasama, Satoru Kakizaki, Jian Gao Fan, Myeong Jun Song, Seung Kew Yoon, Yock Young Dan, Laurentius Lesmana, Khek Yu Ho, Khean Lee Goh, Vincent Wai Sun Wong, Sombat Treeprasertsuk. Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA studyBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01240-z
9
Yala K. Reddy, Hemnishil K. Marella, Yu Jiang, Surosree Ganguli, Peter Snell, Pradeep S.B. Podila, Benedict Maliakkal, Sanjaya K. Satapathy. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver BiopsiesJournal of Clinical and Experimental Hepatology 2020; 10(3): 245 doi: 10.1016/j.jceh.2019.07.002
10
Bokyeong Ryu, Kyung-Yeon Eo, Ja-Jun Jang, C-Yoon Kim, Ji Min Lee, Hanseul Oh, Ukjin Kim, Jin Kim, Hyun-Ho Lee, Young-Mok Jung, Jae-Hak Park. A case of active incomplete biliary cirrhosis in an aged female Japanese macaque (Macaca fuscata )Journal of Medical Primatology 2018; 47(4): 270 doi: 10.1111/jmp.12347
11
T. Çevik Saldiran, F. Karantay Mutluay, I. Yağci, Y. Yilmaz. Comparison of aerobic and combined aerobic and whole-body vibration training effects on physical fitness in non-alcoholic fatty liver patientsComparative Exercise Physiology 2021; 17(4): 393 doi: 10.3920/CEP200075
12
Mohammad Hosein Farzaei, Amit Kumar Singh, Ramesh Kumar, Courtney R. Croley, Abhay K. Pandey, Ericsson Coy-Barrera, Jayanta Kumar Patra, Gitishree Das, Rout George Kerry, Giuseppe Annunziata, Gian Carlo Tenore, Haroon Khan, Matteo Micucci, Roberta Budriesi, Saeideh Momtaz, Seyed Mohammad Nabavi, Anupam Bishayee. Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic DisordersInternational Journal of Molecular Sciences 2019; 20(19): 4957 doi: 10.3390/ijms20194957
13
Mohammed F. Abuzinadah, Aftab Ahmad. Pharmacological studies on the efficacy of a thymoquinone‐containing novel polyherbal formulation against cisplatin‐induced hepatorenal toxicity in ratsJournal of Food Biochemistry 2020; 44(2) doi: 10.1111/jfbc.13131
14
Joselyn N. Allen, Adwitia Dey, Jingwei Cai, Jingtao Zhang, Yuan Tian, Mary Kennett, Yanling Ma, T. Jake Liang, Andrew D. Patterson, Pamela A. Hankey-Giblin. Metabolic Profiling Reveals Aggravated Non-Alcoholic Steatohepatitis in High-Fat High-Cholesterol Diet-Fed Apolipoprotein E-Deficient Mice Lacking Ron Receptor SignalingMetabolites 2020; 10(8): 326 doi: 10.3390/metabo10080326
15
Manuel Suárez, Noemí Boqué, Josep del Bas, Jordi Mayneris-Perxachs, Lluís Arola, Antoni Caimari. Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver DiseaseNutrients 2017; 9(10): 1052 doi: 10.3390/nu9101052
16
Vetriselvan Subramaniyan, Srikumar Chakravarthi, Ravindran Jegasothy, Wu Yuan Seng, Neeraj Kumar Fuloria, Shivkanya Fuloria, Iswar Hazarika, Anju Das. Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapyToxicology Reports 2021; 8: 376 doi: 10.1016/j.toxrep.2021.02.010
17
Stefan Drinda, Franziska Grundler, Thomas Neumann, Thomas Lehmann, Nico Steckhan, Andreas Michalsen, Francoise Wilhelmi de Toledo. Effects of Periodic Fasting on Fatty Liver Index—A Prospective Observational StudyNutrients 2019; 11(11): 2601 doi: 10.3390/nu11112601
18
A. L. Loskutov, I. V. Loskutova. INNATE IMMUNITY IN OSTEOARTHRITIS IN COMORBIDITY WITH NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH HELICOBACTER PYLORI INFECTIONWorld of Medicine and Biology 2021; 17(77): 101 doi: 10.26724/2079-8334-2021-3-77-101-105
19
Mohd Riyazuddin, Arisha Shahid. Non-alcoholic fatty liver disease – discussed under the light of Unani medicineJournal of Complementary and Integrative Medicine 2021; 0(0) doi: 10.1515/jcim-2021-0296
20
Chao-Wu Xiao, Amy Hendry. Hypolipidemic Effects of Soy Protein and Isoflavones in the Prevention of Non-Alcoholic Fatty Liver Disease- A ReviewPlant Foods for Human Nutrition 2022; 77(3): 319 doi: 10.1007/s11130-022-00984-1
21
Dahae Lee, Tuy An Trinh, Myoung-Sook Shin, Ki Sung Kang. Recent Advancements in Microbial Diversity2022; : 209 doi: 10.1016/B978-0-12-822368-0.00009-8
22
Evangelia S. Makri, Eleftheria Makri, Stergios A. Polyzos. Combination Therapies for Nonalcoholic Fatty Liver DiseaseJournal of Personalized Medicine 2022; 12(7): 1166 doi: 10.3390/jpm12071166
23
Athina I. Amanatidou, George V. Dedoussis. Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver diseaseComputers in Biology and Medicine 2021; 131: 104243 doi: 10.1016/j.compbiomed.2021.104243
24
Stephen I. Johnson, Daniel Fort, Kenneth J. Shortt, George Therapondos, Gretchen E. Galliano, Theresa Nguyen, Edward I. Bluth. Ultrasound Stratification of Hepatic Steatosis Using Hepatorenal IndexDiagnostics 2021; 11(8): 1443 doi: 10.3390/diagnostics11081443
25
Yousaf Zafar, Ahmed Mustafa Rashid, Ahmed Kamal Siddiqi, Aayat Ellahi, Aymen Ahmed, Hassan ul Hussain, Furqan Ahmed, Ritesh G. Menezes, Tariq Jamal Siddiqi, Muhammad Talha Maniya. Effect of novel glucose lowering agents on non-alcoholic fatty liver disease: A systematic review and meta-analysisClinics and Research in Hepatology and Gastroenterology 2022; 46(7): 101970 doi: 10.1016/j.clinre.2022.101970
26
Guillermo Rus, Inas H. Faris, Jorge Torres, Antonio Callejas, Juan Melchor. Why Are Viscosity and Nonlinearity Bound to Make an Impact in Clinical Elastographic Diagnosis?Sensors 2020; 20(8): 2379 doi: 10.3390/s20082379
27
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventionsLife Sciences 2021; 271: 119220 doi: 10.1016/j.lfs.2021.119220
28
Andrea A. Florio, Jacques Ferlay, Ariana Znaor, David Ruggieri, Christian S. Alvarez, Mathieu Laversanne, Freddie Bray, Katherine A. McGlynn, Jessica L. Petrick. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012Cancer 2020; 126(11): 2666 doi: 10.1002/cncr.32803
29
Christian S. Alvarez, Andrea A. Florio, Julia Butt, Alvaro Rivera‐Andrade, María F. Kroker‐Lobos, Tim Waterboer, Maria Constanza Camargo, Neal D. Freedman, Barry I. Graubard, Mariana Lazo, Eliseo Guallar, John D. Groopman, Manuel Ramírez‐Zea, Katherine A. McGlynn. Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala Helicobacter 2020; 25(6) doi: 10.1111/hel.12756
30
Cene Skubic, Živa Drakulić, Damjana Rozman. Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugsExpert Opinion on Drug Metabolism & Toxicology 2018; 14(8): 831 doi: 10.1080/17425255.2018.1492552
31
Zixiong Zhou, Jing Qi, Chae Woong Lim, Jong-Won Kim, Bumseok Kim. Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitroToxicology 2020; 444: 152579 doi: 10.1016/j.tox.2020.152579
32
Martin Burian, Milan Hajek, Petr Sedivy, Irena Mikova, Pavel Trunecka, Monika Dezortova. Lipid Profile and Hepatic Fat Content Measured by 1H MR Spectroscopy in Patients before and after Liver TransplantationMetabolites 2021; 11(9): 625 doi: 10.3390/metabo11090625
33
Milena Vesković, Milica Labudović-Borović, Dušan Mladenović, Jelena Jadžić, Bojan Jorgačević, Dušan Vukićević, Danijela Vučević, Tatjana Radosavljević. Effect of Betaine Supplementation on Liver Tissue and Ultrastructural Changes in Methionine–Choline-Deficient Diet-Induced NAFLDMicroscopy and Microanalysis 2020; 26(5): 997 doi: 10.1017/S1431927620024265
34
Moein Askarpour, Kurosh Djafarian, Ehsan Ghaedi, Omid Sadeghi, Ali Sheikhi, Sakineh Shab-Bidar. Effect of L-Carnitine Supplementation on Liver Enzymes: A Systematic Review and Meta-analysis of Randomized Controlled TrialsArchives of Medical Research 2020; 51(1): 82 doi: 10.1016/j.arcmed.2019.12.005
35
Cheng‐Cheng Zhao, Xin‐Yue Wu, Huan Yi, Rong Chen, Gang Fan. The Therapeutic Effects and Mechanisms of Salidroside on Cardiovascular and Metabolic Diseases: An Updated ReviewChemistry & Biodiversity 2021; 18(7) doi: 10.1002/cbdv.202100033
36
Guy Rostoker, Christelle Loridon, Mireille Griuncelli, Clémentine Rabaté, Fanny Lepeytre, Pablo Ureña-Torres, Belkacem Issad, Nasredine Ghali, Yves Cohen. Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept StudyEBioMedicine 2019; 39: 461 doi: 10.1016/j.ebiom.2018.11.020
37
Lipika Salaye, Ielizaveta Bychkova, Sandy Sink, Alexander J. Kovalic, Manish S. Bharadwaj, Felipe Lorenzo, Shalini Jain, Alexandria V. Harrison, Ashley T. Davis, Katherine Turnbull, Nuwan T. Meegalla, Soh-hyun Lee, Robert Cooksey, George L. Donati, Kylie Kavanagh, Herbert L. Bonkovsky, Donald A. McClain. A Low Iron Diet Protects from Steatohepatitis in a Mouse ModelNutrients 2019; 11(9): 2172 doi: 10.3390/nu11092172
38
Reggiani V. Gonçalves, Jamili D.B. Santos, Natanny S. Silva, Etienne Guillocheau, Robson E. Silva, Thaiany G. Souza-Silva, Rafael F. Oliveira, Eliziária C. Santos, Romulo D. Novaes. Trans-fatty acids aggravate anabolic steroid-induced metabolic disturbances and differential gene expression in muscle, pancreas and adipose tissueLife Sciences 2019; 232: 116603 doi: 10.1016/j.lfs.2019.116603
39
Aishwarya Venkatasubramanian, Anand Thiyagaraj, Vairamuthu Subbiah, Solaipriya Solairaja, Sangaran Arumugam, Satish Ramalingam, Sivaramakrishnan Venkatabalasubramanian. Ameliorative role of ellagic acid against acute liver steatosis in adult zebrafish experimental modelComparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 2021; 247: 109061 doi: 10.1016/j.cbpc.2021.109061
40
Eline H. van den Berg, Eke G. Gruppen, Richard W. James, Stephan J.L. Bakker, Robin P.F. Dullaart. Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterolJournal of Lipid Research 2019; 60(1): 168 doi: 10.1194/jlr.P088997
41
Rachelle P. Davis, Bas G. J. Surewaard, Madison Turk, Agostina Carestia, Woo-Yong Lee, Björn Petri, Stefan J. Urbanski, Carla S. Coffin, Craig N. Jenne. Optimization of In vivo Imaging Provides a First Look at Mouse Model of Non-Alcoholic Fatty Liver Disease (NAFLD) Using Intravital MicroscopyFrontiers in Immunology 2020; 10 doi: 10.3389/fimmu.2019.02988
42
Anca Bălănescu, Iustina Stan, Ioana Codreanu, Valentina Comănici, Eugenia Bălănescu, Paul Bălănescu. Circulating Hsp90 Isoform Levels in Overweight and Obese Children and the Relation to Nonalcoholic Fatty Liver Disease: Results from a Cross-Sectional StudyDisease Markers 2019; 2019: 1 doi: 10.1155/2019/9560247
43
Yang Liu, Kevin D. Croft, Jose Caparros-Martin, Fergal O'Gara, Trevor A. Mori, Natalie C. Ward. Beneficial effects of inorganic nitrate in non-alcoholic fatty liver diseaseArchives of Biochemistry and Biophysics 2021; 711: 109032 doi: 10.1016/j.abb.2021.109032
44
Justin D. Schumacher, Grace L. Guo. Bile Acids and Their ReceptorsHandbook of Experimental Pharmacology 2019; 256: 325 doi: 10.1007/164_2019_228
45
Perizat Kanabekova, Adina Kadyrova, Gulsim Kulsharova. Microfluidic Organ-on-a-Chip Devices for Liver Disease Modeling In VitroMicromachines 2022; 13(3): 428 doi: 10.3390/mi13030428
46
Salwa Seddik Hosny, Hanan Mahmoud Ali, Wesam Ahmed Mohammed, Mohamed Hesham El Ghannam. Study of relationship between total vitamin D level and NAFLD in a sample of Egyptian patients with and without T2DMDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(3): 1769 doi: 10.1016/j.dsx.2019.04.002
47
Weiping Wei, Yunqian Li, Yongyong Li, Daoyuan Li. Adipose-specific knockout of ubiquitin-conjugating enzyme E2L6 (Ube2l6) reduces diet-induced obesity, insulin resistance, and hepatic steatosisJournal of Pharmacological Sciences 2021; 145(4): 327 doi: 10.1016/j.jphs.2020.12.008
48
Maria Rubio-Ruiz, Verónica Guarner-Lans, Agustina Cano-Martínez, Eulises Díaz-Díaz, Linaloe Manzano-Pech, Anel Gamas-Magaña, Vicente Castrejón-Tellez, Concepción Tapia-Cortina, Israel Pérez-Torres. Resveratrol and Quercetin Administration Improves Antioxidant DEFENSES and reduces Fatty Liver in Metabolic Syndrome RatsMolecules 2019; 24(7): 1297 doi: 10.3390/molecules24071297
49
Aleksandra Klisic, Ludovico Abenavoli, Sharmila Fagoonee, Nebojsa Kavaric, Gordana Kocic, Ana Ninić. Older age and HDL-cholesterol as independent predictors of liver fibrosis assessed by BARD scoreMinerva Medica 2019; 110(3) doi: 10.23736/S0026-4806.19.05978-0
50
Lívia Pimentel de Sant'Ana, Dalila Juliana S. Ribeiro, Aline Maria Araújo Martins, Fábio Neves dos Santos, Rafael Corrêa, Raquel das Neves Almeida, Marcos Nogueira Eberlin, Corinne F. Maurice, Kelly Grace Magalhães. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese MiceFrontiers in Immunology 2020; 10 doi: 10.3389/fimmu.2019.02926
51
Mohamed Sayed, Ebthal Mahmoud Abozeid, Hoda M. Amin, Naglaa M. Elsayed, Yasser H. Nassar, Hend A. Elsheimy. Non-alcoholic Fatty Liver and Vitamin D Levels in Extremely Obese Individuals: A Case–Control StudyOpen Access Macedonian Journal of Medical Sciences 2021; 9(B): 541 doi: 10.3889/oamjms.2021.5976
52
O.Ya. Babak, N.M. Zhelezniakova, A.O. Rozhdestvenska . The potential role of kallistatin as a new biomarker in non-invasive diagnostics of non-alcoholic fatty liver disease with hypertensionShidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2019; 2019(2): 18 doi: 10.15407/internalmed2019.02.018
53
Aynur Arslan, Özgür Şimşek, Aykut Turhan, Ayşe Çarlıoğlu, Şenay Arıkan, Mustafa Utlu, Emine Kartal Baykan. Non-alcoholic fatty liver disease in patients with familial hypercholesterolemiaOrtadoğu Tıp Dergisi 2020; 12(2): 219 doi: 10.21601/ortadogutipdergisi.722778
54
David Mantle, Iain P Hargreaves. Coenzyme Q10 supplementation in non-alcoholic fatty liver disease: an overviewJournal of Prescribing Practice 2020; 2(4): 200 doi: 10.12968/jprp.2020.2.4.200
55
Katharina L. Hupa, Elmar Jaeckel, Michael P. Manns. Silymarin for Treatment of Nonalcoholic Steatohepatitis–A New Kid on the Block?Clinical Gastroenterology and Hepatology 2017; 15(12): 1863 doi: 10.1016/j.cgh.2017.08.005
56
Ivan M. Petyaev, Pavel Y. Dovgalevsky, Natalia E. Chalyk, Victor A. Klochkov, Nigel H. Kyle, Yuriy K. Bashmakov. Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine: A Preliminary ReportInternational Journal of Chronic Diseases 2018; 2018: 1 doi: 10.1155/2018/4549614
57
Subramaniyam Nithyananthan, Dangudubiyyam Sushmaa, Ibansiewdor Myrthong, Lokanatha Valluru, Shreyoshi Guha, Ishfaq Hassan Mir, Jajnasenee Behera, Chinnasamy Thirunavukkarasu. Curcuma longaandTrigonella foenum graecum‐enriched nutrient mixture from germinatedMacrotyloma uniflorumandVigna radiateameliorate nonalcoholic fatty liver diseases in ratsJournal of Food Biochemistry 2020; 44(4) doi: 10.1111/jfbc.13159
58
Eunha Chang, Jae Seung Chang, In Deok Kong, Soon Koo Baik, Moon Young Kim, Kyu-Sang Park. Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver DiseaseGut and Liver 2022; 16(2): 171 doi: 10.5009/gnl210106
59
Bahman Rostama, Megan Beauchemin, Celeste Bouchard, Elizabeth Bernier, Calvin P. H. Vary, Meghan May, Karen L. Houseknecht. Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in MiceInternational Journal of Molecular Sciences 2020; 21(24): 9362 doi: 10.3390/ijms21249362
60
Hye In Kim, Jeon-Kyung Kim, Jae-Young Kim, Se-Eun Jang, Myung Joo Han, Dong-Hyun Kim. Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 simultaneously alleviate high-fat diet-induced colitis, endotoxemia, liver steatosis, and obesity in miceNutrition Research 2019; 67: 78 doi: 10.1016/j.nutres.2019.03.008
61
Raushan Kumar, Jitendra Kumar Arya, Syed Ibrahim Rizvi. Chitosan reduces inflammation and protects against oxidative stress in a hyperlipidemic rat model: relevance to nonalcoholic fatty liver diseaseMolecular Biology Reports 2022; 49(10): 9465 doi: 10.1007/s11033-022-07810-6
62
Karilyn E. Sant, Hadley M. Moreau, Larissa M. Williams, Haydee M. Jacobs, Anna M. Bowsher, Jason D. Boisvert, Roxanna M. Smolowitz, Jacob Pantazis, Kate Annunziato, Malina Nguyen, Alicia Timme-Laragy. Embryonic exposures to mono-2-ethylhexyl phthalate induce larval steatosis in zebrafish independent of Nrf2a signalingJournal of Developmental Origins of Health and Disease 2021; 12(1): 132 doi: 10.1017/S2040174420000057
63
Xin Jiang, Fan Zhang, Xueying Ji, Fangyuan Dong, Huiyuan Yu, Mengjuan Xue, Yixuan Qiu, Fan Yang, Xiaona Hu, Zhijun Bao. Lipid-injured hepatocytes release sOPN to improve macrophage migration via CD44 engagement and pFak-NFκB signalingCytokine 2021; 142: 155474 doi: 10.1016/j.cyto.2021.155474
64
Fabiana Kurokawa Hasimoto, Fabiane Valentini Francisqueti-Ferron, Mariane Róvero Costa, Marajane Bruno de Souza, Aline Garcia Aun, Flávia Ribeiro Nogueira, Pedro Henrique Rizzi Alves, Giuseppina Pace Pereira Lima, Jéssica Leite Garcia, Carol Cristina Vágula de Almeida Silva, Artur Junio Togneri Ferron, Igor Otávio Minatel, Fernando Moreto, Mariana Gobbo Braz, Camila Renata Corrêa. Therapeutic effect of Curcuma longa L. on the nonalcoholic fatty liver disease (NAFLD) physiopathology due fructose consumptionNutrire 2020; 45(2) doi: 10.1186/s41110-020-00127-z
65
P. Melendez, M. Whitney, F. Williams, P. Pinedo, D. Manriquez, S.G. Moore, M.C. Lucy, P. Pithua, S.E. Poock. Technical note: Evaluation of fine needle aspiration cytology for the diagnosis of fatty liver in dairy cattleJournal of Dairy Science 2018; 101(5): 4483 doi: 10.3168/jds.2017-13346
66
Vik Meadows, Lindsey Kennedy, Debjyoti Kundu, Gianfranco Alpini, Heather Francis. Bile Acid Receptor Therapeutics Effects on Chronic Liver DiseasesFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00015
67
Meltem Yalçın, Mehtap Kaçar. Investigation of the hepatic mTOR/S6K1/SREBP1 signalling pathway in rats at different ages: from neonates to adultsMolecular Biology Reports 2021; 48(11): 7415 doi: 10.1007/s11033-021-06757-4
68
Lung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, Harrys A. Torres, Noelle K. LoConte, John P. Rice, Lewis E. Foxhall, Erich M. Sturgis, Janette K. Merrill, Howard H. Bailey, Nahum Méndez-Sánchez, Man-Fung Yuen, Jessica P. Hwang. Global Epidemiology, Prevention, and Management of Hepatocellular CarcinomaAmerican Society of Clinical Oncology Educational Book 2018; (38): 262 doi: 10.1200/EDBK_200939
69
Nicholas D. Johnson, Xiumei Wu, Christopher D. Still, Xin Chu, Anthony T. Petrick, Glenn S. Gerhard, Karen N. Conneely, Johanna K. DiStefano. Differential DNA methylation and changing cell-type proportions as fibrotic stage progresses in NAFLDClinical Epigenetics 2021; 13(1) doi: 10.1186/s13148-021-01129-y
70
Fatemeh Izadi, Amirhosein Farrokhzad, Babak Tamizifar, Mohammad Javad Tarrahi, Mohammad Hassan Entezari. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non‐alcoholic fatty liver disease: A double‐blind randomized controlled clinical trialPhytotherapy Research 2021; 35(1): 477 doi: 10.1002/ptr.6826
71
Md. Abdul Hannan, Md. Ataur Rahman, Abdullah Al Mamun Sohag, Md. Jamal Uddin, Raju Dash, Mahmudul Hasan Sikder, Md. Saidur Rahman, Binod Timalsina, Yeasmin Akter Munni, Partha Protim Sarker, Mahboob Alam, Md. Mohibbullah, Md. Nazmul Haque, Israt Jahan, Md. Tahmeed Hossain, Tania Afrin, Md. Mahbubur Rahman, Md. Tahjib-Ul-Arif, Sarmistha Mitra, Diyah Fatimah Oktaviani, Md Kawsar Khan, Ho Jin Choi, Il Soo Moon, Bonglee Kim. Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and SafetyNutrients 2021; 13(6): 1784 doi: 10.3390/nu13061784
72
E. Cipponeri, N. Vitturi, V. Mariano, F. Boscari, S. Galasso, C. Crepaldi, G. P. Fadini, S. Vigili de Kreutzenberg, M. C. Marescotti, E. Iori, F. Cavallin, L. Sartori, A. Baritussio, A. Avogaro, D. Bruttomesso. Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetesJournal of Endocrinological Investigation 2019; 42(9): 1099 doi: 10.1007/s40618-019-01031-8
73
Jinping Lai, Hanlin L. Wang, Xuchen Zhang, Huamin Wang, Xiuli Liu. Pathologic Diagnosis of Nonalcoholic Fatty Liver DiseaseArchives of Pathology & Laboratory Medicine 2022; 146(8): 940 doi: 10.5858/arpa.2021-0339-RA
74
Kush Kumar Pandey, Deeksha Madhry, Y.S. Ravi Kumar, Shivani Malvankar, Leena Sapra, Rupesh K. Srivastava, Sankar Bhattacharyya, Bhupendra Verma. Regulatory roles of tRNA-derived RNA fragments in human pathophysiologyMolecular Therapy - Nucleic Acids 2021; 26: 161 doi: 10.1016/j.omtn.2021.06.023
75
Chuang Li, Weiwei Kong, Lixia Kang, Tiehan Zhang, Weiqun Zhang, Weidong Wang. Study on the correlation between urinary retinol-binding protein and nonalcoholic fatty liver diseaseJournal of Medical Biochemistry 2021; 40(1): 86 doi: 10.5937/jomb0-24666
76
Shuai Chen, Yicheng Jiang, Xiaoyang Qi, Peng Song, Liming Tang, Hanyang Liu. Bioinformatics analysis to obtain critical genes regulated in subcutaneous adipose tissue after bariatric surgeryAdipocyte 2022; 11(1): 550 doi: 10.1080/21623945.2022.2115212
77
Eyun Song, Jung A. Kim, Eun Roh, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A. Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Kyung Mook Choi. Long Working Hours and Risk of Nonalcoholic Fatty Liver Disease: Korea National Health and Nutrition Examination Survey VIIFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.647459
78
Sylwia Szeląg-Pieniek, Stefan Oswald, Mariola Post, Joanna Łapczuk-Romańska, Marek Droździk, Mateusz Kurzawski. Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failurePharmacological Reports 2021; 73(5): 1427 doi: 10.1007/s43440-021-00290-8
79
John C. Parker, Andreas G. Moraitis, Joseph K. Belanoff. Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With HypercortisolismAACE Clinical Case Reports 2022; 8(1): 25 doi: 10.1016/j.aace.2021.07.001
80
Daiane T. Oliveira, Adriano B. Chaves-Filho, Marcos Y. Yoshinaga, Nívia Carolina N. Paiva, Cláudia M. Carneiro, Sayuri Miyamoto, William T. Festuccia, Renata Guerra-Sá. Liver lipidome signature and metabolic pathways in nonalcoholic fatty liver disease induced by a high-sugar dietThe Journal of Nutritional Biochemistry 2021; 87: 108519 doi: 10.1016/j.jnutbio.2020.108519
81
Ashley Cast, Meenasri Kumbaji, Amber D'Souza, Katherine Rodriguez, Anita Gupta, Rebekah Karns, Lubov Timchenko, Nikolai Timchenko. Liver Proliferation Is an Essential Driver of Fibrosis in Mouse Models of Nonalcoholic Fatty Liver DiseaseHepatology Communications 2019; 3(8): 1036 doi: 10.1002/hep4.1381
82
Bingqian Wang, Wenna Li, Hezhi Fang, Huaibin Zhou. Hepatitis B virus infection is not associated with fatty liver disease: Evidence from a cohort study and functional analysisMolecular Medicine Reports 2018;  doi: 10.3892/mmr.2018.9619
83
Feng-Juan Yan, Yong-Jian Wang, Shi-Ran Yan, Jun Lu, Yuan-Lin Zheng. ZNF300 stimulates fatty acid oxidation and alleviates hepatosteatosis through regulating PPARαBiochemical Journal 2019; 476(2): 385 doi: 10.1042/BCJ20180517
84
Giacinto Libertini, Graziamaria Corbi, Valeria Conti, Olga Shubernetskaya, Nicola Ferrara. Evolutionary Gerontology and GeriatricsAdvances in Studies of Aging and Health 2021; 2: 291 doi: 10.1007/978-3-030-73774-0_7
85
Evaluation of hepcidin and its relationship with iron in non-alcoholic fatty liver diseaseBiomedicine 2022; 42(1): 173 doi: 10.51248/.v42i1.680
86
Beyza Bulutoglu, Camilo Rey-Bedón, Young Bok (Abraham) Kang, Safak Mert, Martin L. Yarmush, O. Berk Usta. A microfluidic patterned model of non-alcoholic fatty liver disease: applications to disease progression and zonationLab on a Chip 2019; 19(18): 3022 doi: 10.1039/C9LC00354A
87
Naveen Kaushal, Megha Gupta, Era Kulshreshtha. Hempseed (Cannabis sativa) lipid fractions alleviate high-fat diet-induced fatty liver disease through regulation of inflammation and oxidative stressHeliyon 2020; 6(7): e04422 doi: 10.1016/j.heliyon.2020.e04422
88
Soufian Lasli, Han‐Jun Kim, KangJu Lee, Ceri‐Anne E. Suurmond, Marcus Goudie, Praveen Bandaru, Wujin Sun, Shiming Zhang, Niyuan Zhang, Samad Ahadian, Mehmet R. Dokmeci, Junmin Lee, Ali Khademhosseini. A Human Liver‐on‐a‐Chip Platform for Modeling Nonalcoholic Fatty Liver DiseaseAdvanced Biosystems 2019; 3(8): 1900104 doi: 10.1002/adbi.201900104
89
Stuart C. Gordon, Jeremy Fraysse, Suying Li, A. Burak Ozbay, Robert J. Wong. Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare PatientsAmerican Journal of Gastroenterology 2020; 115(4): 562 doi: 10.14309/ajg.0000000000000484
90
Nahum Méndez-Sánchez, Eira Cerda-Reyes, Fátima Higuera-de-la-Tijera, Ana K. Salas-García, Samantha Cabrera-Palma, Guillermo Cabrera-Álvarez, Carlos Cortez-Hernández, Luis A Pérez-Arredondo, Emma Purón-González, Edgar Coronado-Alejandro, Arturo Panduro, Heriberto Rodríguez-Hernández, Vania C. Cruz-Ramón, Alejandro Valencia-Rodríguez, Xingshun Qi, Nashla Hamdan-Pérez, Nancy E. Aguilar-Olivos, Beatriz Barranco-Fragoso, Oscar Ramírez-Pérez, Alfonso Vera-Barajas. Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitisF1000Research 2020; 9: 56 doi: 10.12688/f1000research.21918.1
91
Zahra Maleki, Shima Jazayeri, Omid Eslami, Farzad Shidfar, Agha Fatemeh Hosseini, Shahram Agah, Hamed Norouzi. Effect of soy milk consumption on glycemic status, blood pressure, fibrinogen and malondialdehyde in patients with non-alcoholic fatty liver disease: a randomized controlled trialComplementary Therapies in Medicine 2019; 44: 44 doi: 10.1016/j.ctim.2019.02.020
92
Musaab Ahmed, Mohamed H Ahmed. Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemicWorld Journal of Clinical Cases 2021; 9(17): 4133-4142 doi: 10.12998/wjcc.v9.i17.4133
93
Enxiang Zhang, Shutao Yin, Chong Zhao, Lihong Fan, Hongbo Hu. Involvement of activation of PLIN5-Sirt1 axis in protective effect of glycycoumarin on hepatic lipotoxicityBiochemical and Biophysical Research Communications 2020; 528(1): 7 doi: 10.1016/j.bbrc.2020.05.072
94
Jitka Starekova, Scott B. Reeder. Liver fat quantification: where do we stand?Abdominal Radiology 2020; 45(11): 3386 doi: 10.1007/s00261-020-02783-1
95
Danijela Ristic-Medic, Joanna Bajerska, Vesna Vucic. Crosstalk between dietary patterns, obesity and nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2022; 28(27): 3314-3333 doi: 10.3748/wjg.v28.i27.3314
96
Jie Xing, Xue Guan, Qian Zhang, Shuohua Chen, Shouling Wu, Xiujing Sun. Triglycerides Mediate Body Mass Index and Nonalcoholic Fatty Liver Disease: A Population-Based StudyObesity Facts 2021; 14(2): 190 doi: 10.1159/000514848
97
Juan-Fen Mo, Jia-Yuan Wu, Li Zheng, Ya-Wei Yu, Tian-Xin Zhang, Li Guo, Yi Bao. Therapeutic efficacy of polydatin for nonalcoholic fatty liver disease via regulating inflammatory response in obese miceRSC Advances 2018; 8(54): 31194 doi: 10.1039/C8RA05915B
98
Matthew T. Goodus, Dana M. McTigue. Hepatic dysfunction after spinal cord injury: A vicious cycle of central and peripheral pathology?Experimental Neurology 2020; 325: 113160 doi: 10.1016/j.expneurol.2019.113160
99
Emma Henriksson, Birgitte Andersen. FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to HumanFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.601349
100
Zain Moosvi, Felix H. Lui, Douglas Nguyen. Liver Diseases2020; : 407 doi: 10.1007/978-3-030-24432-3_35
101
Xiao Li, Virgia Wang. Genetic evidence for the causal relationship between NAFLD and brain functional connectivity2022 6th International Conference on Biomedical Engineering and Applications (ICBEA) 2022; : 77 doi: 10.1145/3543081.3543093
102
Arunaksharan Narayanankutty. Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic DiseasesCurrent Drug Targets 2019; 20(10): 1068 doi: 10.2174/1389450120666190222181506
103
Chris Boesch. Quantitative MR Imaging Is Increasingly Important in Liver DiseaseRadiology 2018; 286(2): 557 doi: 10.1148/radiol.2017172312
104
Pierangelo Torquato, Desirée Bartolini, Danilo Giusepponi, Marta Piroddi, Bartolomeo Sebastiani, Giorgio Saluti, Roberta Galarini, Francesco Galli. Increased plasma levels of the lipoperoxyl radical-derived vitamin E metabolite α-tocopheryl quinone are an early indicator of lipotoxicity in fatty liver subjectsFree Radical Biology and Medicine 2019; 131: 115 doi: 10.1016/j.freeradbiomed.2018.11.036
105
Hany A. Abdel Samie, Mohd Saeed, Syed Mohd Faisal, Mohd Adnan Kausar, Mohammad A. Kamal. Recent Findings on Nanotechnology-based Therapeutic Strategies Against Hepatocellular CarcinomaCurrent Drug Metabolism 2019; 20(4): 283 doi: 10.2174/1389200220666190308134351
106
Robin H. Isaacson, Juliane I. Beier, Nicholas KH Khoo, Bruce A. Freeman, Zachary Freyberg, Gavin E. Arteel. Olanzapine-induced liver injury in mice: aggravation by high-fat diet and protection with sulforaphaneThe Journal of Nutritional Biochemistry 2020; 81: 108399 doi: 10.1016/j.jnutbio.2020.108399
107
Veronica A. Mullins, William Bresette, Laurel Johnstone, Brian Hallmark, Floyd H. Chilton. Genomics in Personalized Nutrition: Can You “Eat for Your Genes”?Nutrients 2020; 12(10): 3118 doi: 10.3390/nu12103118
108
Paul F. Lebeau, Jae Hyun Byun, Khrystyna Platko, Melissa E. MacDonald, Samantha V. Poon, Mahi Faiyaz, Nabil G. Seidah, Richard C. Austin. Diet-induced hepatic steatosis abrogates cell-surface LDLR by inducing de novo PCSK9 expression in miceJournal of Biological Chemistry 2019; 294(23): 9037 doi: 10.1074/jbc.RA119.008094
109
Tahmine Tavakoli, Asghar Zarban, Reyhaneh Hooshyar, Fatemeh Salmani, Hamidreza Tajik. Improvement of thiol groups and total antioxidant capacity in patients with non-alcoholic fatty liver after treatment with pioglitazoneArchives of Physiology and Biochemistry 2020; : 1 doi: 10.1080/13813455.2020.1784953
110
Xiaofang Zhang, Caoxin Huang, Xuejun Li, Zhaoshui Shangguan, Wenjing Wei, Suhuan Liu, Shuyu Yang, Yijie Liu. HFD and HFD-provoked hepatic hypoxia act as reciprocal causation for NAFLD via HIF-independent signalingBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01515-5
111
Zahra Koohestani Sini, Mohammad Esmaeil Afzalpour, Mohsen Mohammadnia Ahmadi, Mohammad Ali Sardar, Sattar Gorgani Firuzjaee. The Effect of Aerobic Continuous Training on Myonectin, Insulin Resistance and Liver Enzymes in Rats with Nonalcoholic Fatty Liver DiseaseAnnals of Applied Sport Science 2020; 8(4): 0 doi: 10.29252/aassjournal.855
112
Jelena Mustra Rakic, Chun Liu, Sudipta Veeramachaneni, Dayong Wu, Ligi Paul, Lynne M. Ausman, Xiang-Dong Wang. Dietary lycopene attenuates cigarette smoke-promoted nonalcoholic steatohepatitis by preventing suppression of antioxidant enzymes in ferretsThe Journal of Nutritional Biochemistry 2021; 91: 108596 doi: 10.1016/j.jnutbio.2021.108596
113
Fatemeh Naeini, Zahra Namkhah, Helda Tutunchi, Seyed Mahdi Rezayat, Siavash Mansouri, Seyed Ali Jazayeri-Tehrani, Mehdi Yaseri, Mohammad Javad Hosseinzadeh-Attar. Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trialTrials 2021; 22(1) doi: 10.1186/s13063-021-05784-7
114
Esther van Eekelen, Anouk Geelen, Marjan Alssema, Hildo J. Lamb, Albert de Roos, Frits R. Rosendaal, Renée de Mutsert. Adherence to dietary guidelines in relation to visceral fat and liver fat in middle-aged men and women: the NEO studyInternational Journal of Obesity 2020; 44(2): 297 doi: 10.1038/s41366-019-0441-x
115
Yuanyuan Zhang, Juyi Li, Huaizhen Liu. Correlation between the thyroid hormone levels and nonalcoholic fatty liver disease in type 2 diabetic patients with normal thyroid functionBMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01050-2
116
Sadia Ashraf, Nadia Ashraf, Gizem Yilmaz, Romain Harmancey. Crosstalk between beta‐adrenergic and insulin signaling mediates mechanistic target of rapamycin hyperactivation in liver of high‐fat diet‐fed male micePhysiological Reports 2021; 9(13) doi: 10.14814/phy2.14958
117
Yuhei Mizunoe, Masaki Kobayashi, Ryoma Tagawa, Yoshimi Nakagawa, Hitoshi Shimano, Yoshikazu Higami. Association between Lysosomal Dysfunction and Obesity-Related Pathology: A Key Knowledge to Prevent Metabolic SyndromeInternational Journal of Molecular Sciences 2019; 20(15): 3688 doi: 10.3390/ijms20153688
118
AssimA Alfadda, SuphiaM Sherbeeni, AdelN Alqutub, AbdullahS Aldosary, NasserM Aldaghri, SimonD Taylor-Robinson, SalehA Alqahtani, Rukhsana Gul, AbdulrahmanM Almaghamsi. Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort studySaudi Journal of Gastroenterology 2022; 0(0): 0 doi: 10.4103/sjg.sjg_73_22
119
David Mantle, Iain P Hargreaves. Coenzyme Q10 supplementation in non-alcoholic fatty liver disease: an overviewGastrointestinal Nursing 2020; 18(2): 22 doi: 10.12968/gasn.2020.18.2.22
120
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. The Mexican consensus on nonalcoholic fatty liver diseaseRevista de Gastroenterología de México (English Edition) 2019; 84(1): 69 doi: 10.1016/j.rgmxen.2019.02.003
121
Saimila Momin, Ganji Purnachandra Nagaraju. Novel therapeutic approaches for gastrointestinal malignanciesDiagnostics and Therapeutic Advances in GI Malignancies 2020; : 253 doi: 10.1007/978-981-15-5471-1_15
122
Michael J. Nash, Evgenia Dobrinskikh, Sean A. Newsom, Ilhem Messaoudi, Rachel C. Janssen, Kjersti M. Aagaard, Carrie E. McCurdy, Maureen Gannon, Paul Kievit, Jacob E. Friedman, Stephanie R. Wesolowski. Maternal Western diet exposure increases periportal fibrosis beginning in utero in nonhuman primate offspringJCI Insight 2021; 6(24) doi: 10.1172/jci.insight.154093
123
Kelsey Retting, Dwayne Carter, Candace Crogan-Grundy, Chirag Khatiwala, Leah Norona, Elizabeth Paffenroth, Umesh Hanumegowda, Alice Chen, Lisa Hazelwood, Lois Lehman-McKeeman, Sharon Presnell. Modeling Liver Biology and the Tissue Response to Injury in Bioprinted Human Liver TissuesApplied In Vitro Toxicology 2018; 4(3): 288 doi: 10.1089/aivt.2018.0015
124
Alper Sonmez, Cemal Nuri Ercin, Mustafa Cesur, Teoman Dogru. Nutraceuticals and Cardiovascular DiseaseContemporary Cardiology 2021; : 141 doi: 10.1007/978-3-030-62632-7_9
125
Qian Chen, Mengyang Liu, Haiyang Yu, Jian Li, Sijian Wang, Yi Zhang, Feng Qiu, Tao Wang. Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathwayJournal of Natural Medicines 2018; 72(3): 655 doi: 10.1007/s11418-018-1199-5
126
Meghan May, Deborah Barlow, Radwa Ibrahim, Karen L. Houseknecht. Mechanisms Underlying Antipsychotic-Induced NAFLD and Iron Dysregulation: A Multi-Omic ApproachBiomedicines 2022; 10(6): 1225 doi: 10.3390/biomedicines10061225
127
İsa Çam, Ural Koc, Samet Genez, Abdullah Güneş. Computed Tomography Measurements of Hepatic Steatosis in Cholelitihiasis and Cholecystectomy Cases Using Unenhanced ImagesJournal of Medical Imaging and Radiation Sciences 2020; 51(1): 137 doi: 10.1016/j.jmir.2019.12.003
128
Geng-Ruei Chang, Hsien-Yueh Liu, Wei-Cheng Yang, Chao-Min Wang, Ching-Fen Wu, Jen-Wei Lin, Wei-Li Lin, Yu-Chen Wang, Tzu-Chun Lin, Huei-Jyuan Liao, Po-Hsun Hou, Chee-Hong Chan, Chuen-Fu Lin. Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese MiceInternational Journal of Molecular Sciences 2021; 22(13): 6680 doi: 10.3390/ijms22136680
129
Cátia Arieira, Sara Monteiro, Sofia Xavier, Francisca Dias de Castro, Joana Magalhães, Maria J. Moreira, Carla Marinho, José Cotter. Hepatic steatosis and patients with inflammatory bowel disease: when transient elastography makes the differenceEuropean Journal of Gastroenterology & Hepatology 2019; 31(8): 998 doi: 10.1097/MEG.0000000000001319
130
Yuchang Li, Liting Chen, Lu Li, Chantal Sottas, Stephanie K. Petrillo, Anthoula Lazaris, Peter Metrakos, Hangyu Wu, Yuji Ishida, Takeshi Saito, Lucy Golden-Mason, Hugo R. Rosen, Jeremy J. Wolff, Cristina I. Silvescu, Samuel Garza, Garett Cheung, Tiffany Huang, Jinjiang Fan, Martine Culty, Bangyan Stiles, Kinji Asahina, Vassilios Papadopoulos. Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver diseaseiScience 2021; 24(5): 102457 doi: 10.1016/j.isci.2021.102457
131
Joseph Carpenter, Gang Wu, Ying Wang, Erica M. Cook, Tao Wang, Doree Sitkoff, Karen A. Rossi, Kathy Mosure, Xiaoliang Zhuo, Gary G. Cao, Milinda Ziegler, Anthony V. Azzara, Jack Krupinski, Matthew G. Soars, Bruce Alan Ellsworth, Dean A. Wacker. Discovery of BMS-986318, a Potent Nonbile Acid FXR Agonist for the Treatment of Nonalcoholic SteatohepatitisACS Medicinal Chemistry Letters 2021; 12(9): 1413 doi: 10.1021/acsmedchemlett.1c00198
132
Getnet Teshome, Sintayehu Ambachew, Alebachew Fasil, Molla Abebe. <p>Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review</p>Hepatic Medicine: Evidence and Research 2020; : 139 doi: 10.2147/HMER.S265631
133
Erenius Toppo, Naif Abdullah Al-Dhabi, Chinnakulandai Sankar, Sanmugapriya Nagul Kumar, Kanniappan Buvanesvaragurunathan, Santhanam Sylvester Darvin, Antony Stalin, Kedeke Balakrishna, Stanislaus Antony Ceasar, Perumal Pandikumar, Savarimuthu Ignacimuthu, Kuppusamy Sivasankaran, Paul Agastian. Hepatoprotective effect of selected isoandrographolide derivatives on steatotic HepG2 cells and High Fat Diet fed ratsEuropean Journal of Pharmacology 2021; 899: 174056 doi: 10.1016/j.ejphar.2021.174056
134
Charlotte D’Mello, Mark G. Swain. The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes2021; : 205 doi: 10.1016/B978-0-12-821927-0.00007-3
135
Gary A. Abrams, Deanna Ware, Margaret M. Byrne, Eric M. Hecht. Risk stratification of adolescents for the screening of non‐alcoholic fatty liver disease Pediatric Obesity 2022; 17(9) doi: 10.1111/ijpo.12924
136
Faisal M Sanai, Faisal Abaalkhail, Fuad Hasan, Muhammad Hamed Farooqi, Nawal Al Nahdi, Zobair M Younossi. Management of nonalcoholic fatty liver disease in the Middle EastWorld Journal of Gastroenterology 2020; 26(25): 3528-3541 doi: 10.3748/wjg.v26.i25.3528
137
Chang Li, Jing Ye, Yun Peng, Weiqiang Dou, Songan Shang, Jingtao Wu, Ramin Jafari, Kelly McCabe Gillen, Yi Wang, Martin Prince, Xianfu Luo. Evaluation of diffusion kurtosis imaging in stratification of nonalcoholic fatty liver disease and early diagnosis of nonalcoholic steatohepatitis in a rabbit modelMagnetic Resonance Imaging 2019; 63: 267 doi: 10.1016/j.mri.2019.08.032
138
Ângela Fernandes, Ana M. Dias, Mariana C. Silva, Joana Gaifem, Catarina M. Azevedo, Iago Carballo, Salomé S. Pinho. Comprehensive Glycoscience2021; : 444 doi: 10.1016/B978-0-12-819475-1.00036-5
139
Bingwei Ma, Hang Sun, Bing Zhu, Shilin Wang, Lei Du, Xingchun Wang, Shen Qu. Hepatic Steatosis Is Associated with Elevated Serum Iron in Patients with Obesity and Improves after Laparoscopic Sleeve GastrectomyObesity Facts 2021; 14(1): 64 doi: 10.1159/000511736
140
Esther Rey, Elvira del Pozo-Maroto, Patricia Marañón, Brittany Beeler, Yaiza García-García, Pedro Landete, Stephania C. Isaza, Ramón Farré, Carmelo García-Monzón, Isaac Almendros, Águeda González-Rodríguez. Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep ApneaFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00450
141
Xiaoyan Hao, Cong Ma, Tianyuan Xiang, Lei Ou, Qiang Zeng. Associations Among Methylene Tetrahydrofolate Reductase rs1801133 C677T Gene Variant, Food Groups, and Non-alcoholic Fatty Liver Disease Risk in the Chinese PopulationFrontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.568398
142
Di-Shuang Hu, Sheng-Hao Zhu, Xu Li, Qin-Fen Chen, Chun-Jing Lin, Dan-Hong Fang, Jian-Sheng Wu. Association between Hemoglobin Glycation Index and NAFLD in Chinese Nondiabetic IndividualsCanadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/8748459
143
Jinchunzi Yang, Marta Fernández-Galilea, Leyre Martínez-Fernández, Pedro González-Muniesa, Adriana Pérez-Chávez, J. Alfredo Martínez, Maria J. Moreno-Aliaga. Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid SupplementationNutrients 2019; 11(4): 872 doi: 10.3390/nu11040872
144
Ali Kermanizadeh, Jessica Valli, Katarzyna Sanchez, Simon Hutter, Agnieszka Pawlowska, Graeme Whyte, Wolfgang Moritz, Vicki Stone. Particulate and drug-induced toxicity assessed in novel quadruple cell human primary hepatic disease models of steatosis and pre-fibrotic NASHArchives of Toxicology 2022; 96(1): 287 doi: 10.1007/s00204-021-03181-2
145
Cristina Carvalho, Paula I. Moreira. Obesity and Diabetes2020; : 399 doi: 10.1007/978-3-030-53370-0_29
146
Farah D.R. Al-Baiaty, Aziana Ismail, Zarina Abdul Latiff, Khairul Najmi Muhammad Nawawi, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar. Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and AdolescentsFrontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.667247
147
Marco Raffaele, Lars Bellner, Shailendra P. Singh, Gaia Favero, Rita Rezzani, Luigi Fabrizio Rodella, John R. Falck, Nader G. Abraham, Luca Vanella. Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in HO-1-PGC1α mitochondrial signalingExperimental Cell Research 2019; 380(2): 180 doi: 10.1016/j.yexcr.2019.04.029
148
Doaa El Amrousy, Dina Abdelhai, Dina Shawky. Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trialEuropean Journal of Pediatrics 2022; 181(2): 579 doi: 10.1007/s00431-021-04243-4
149
Arne Janssen, Diederick E Grobbee, Paul Dendale. Non-alcoholic fatty liver disease, a new and growing risk indicator for cardiovascular diseaseEuropean Journal of Preventive Cardiology 2020; 27(10): 1059 doi: 10.1177/2047487319891783
150
Ewa Garbiec, Judyta Cielecka-Piontek, Magdalena Kowalówka, Magdalena Hołubiec, Przemysław Zalewski. Genistein—Opportunities Related to an Interesting Molecule of Natural OriginMolecules 2022; 27(3): 815 doi: 10.3390/molecules27030815
151
Lin Xu, Yuanjun Lu, Ning Wang, Yibin Feng. The Role and Mechanisms of Selenium Supplementation on Fatty Liver-Associated DisorderAntioxidants 2022; 11(5): 922 doi: 10.3390/antiox11050922
152
Tristan Joseph C. Limchesing, Nilo T. Bugtai, Renann G. Baldovino. Implementation of Neural Network for the Liver Disease Classification2020 International Conference on Applied Science and Technology (iCAST) 2020; : 549 doi: 10.1109/iCAST51016.2020.9557639
153
Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov. Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromesDiabetes mellitus 2018; 20(6): 449 doi: 10.14341/DM9374
154
Isabel Hidalgo, Miguel Ortiz-Flores, Francisco Villarreal, Salvador Fonseca-Coronado, Guillermo Ceballos, Eduardo Meaney, Nayelli Nájera. Is it possible to treat nonalcoholic liver disease using a flavanol-based nutraceutical approach? Basic and clinical dataJournal of Basic and Clinical Physiology and Pharmacology 2022; 0(0) doi: 10.1515/jbcpp-2021-0285
155
Xiaozhong Huang, Fan Lee, Yao Teng, Corey Bryen Lingam, Zijian Chen, Min Sun, Ziwei Song, Gowri M. Balachander, Hwa Liang Leo, Qiongyu Guo, Imran Shah, Hanry Yu. Sequential drug delivery for liver diseasesAdvanced Drug Delivery Reviews 2019; : 72 doi: 10.1016/j.addr.2019.11.001
156
Eréndira Villanueva-Ortega, María José Garcés-Hernández, Arturo Herrera-Rosas, Juan Carlos López-Alvarenga, Estibalitz Laresgoiti-Servitje, Galileo Escobedo, Gloria Queipo, Sergio Cuevas-Covarrubias, Guadalupe Nayely Garibay-Nieto. Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric populationAnnals of Hepatology 2019; 18(5): 693 doi: 10.1016/j.aohep.2019.04.012
157
Mohamed Mostafa, Amrou Abdelkader, John J. Evans, Catherine E. Hagen, Christopher P. Hartley. Fatty Liver Disease: A Practical ApproachArchives of Pathology & Laboratory Medicine 2020; 144(1): 62 doi: 10.5858/arpa.2019-0341-RA
158
Zuo-Di Fu, Xiao-Ling Cai, Wen-Jia Yang, Ming-Ming Zhao, Ran Li, Yu-Feng Li. Novel glucose-lowering drugs for non-alcoholic fatty liver diseaseWorld Journal of Diabetes 2021; 12(1): 84-97 doi: 10.4239/wjd.v12.i1.84
159
Emma Wilkinson, Yan-Hong Cui, Yu-Ying He. Context-Dependent Roles of RNA Modifications in Stress Responses and DiseasesInternational Journal of Molecular Sciences 2021; 22(4): 1949 doi: 10.3390/ijms22041949
160
Selin Gencer, Yvonne Döring, Yvonne Jansen, Soyolmaa Bayasgalan, Olga Schengel, Madeleine Müller, Linsey J. F. Peters, Christian Weber, Emiel P. C. van der Vorst. Adipocyte-Specific ACKR3 Regulates Lipid Levels in Adipose TissueBiomedicines 2021; 9(4): 394 doi: 10.3390/biomedicines9040394
161
Carolyne Pimentel Rosado, Victor Hugo Cordeiro Rosa, Bruna Cadete Martins, Aruanna Cajaty Soares, Izabelle Barcellos Santos, Elisa Bernardes Monteiro, Nathália Moura-Nunes, Cristiane Aguiar da Costa, Alessandra da Rocha Pinheiro Mulder, Julio Beltrame Daleprane. Resistant starch from green banana (Musa sp.) attenuates non-alcoholic fat liver accumulation and increases short-chain fatty acids production in high-fat diet-induced obesity in miceInternational Journal of Biological Macromolecules 2020; 145: 1066 doi: 10.1016/j.ijbiomac.2019.09.199
162
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. Consenso mexicano de la enfermedad por hígado graso no alcohólicoRevista de Gastroenterología de México 2019; 84(1): 69 doi: 10.1016/j.rgmx.2018.11.007
163
Elizabeth J. Millings, Maria Caterina De Rosa, Sarah Fleet, Kazuhisa Watanabe, Richard Rausch, Dieter Egli, Gen Li, Charles A. Leduc, Yiying Zhang, Stuart G. Fischer, Rudolph L. Leibel, Leonidas G. Koniaris. ILDR2 has a negligible role in hepatic steatosisPLOS ONE 2018; 13(5): e0197548 doi: 10.1371/journal.pone.0197548
164
Kiarash Riazi, Maitreyi Raman, Lorian Taylor, Mark G. Swain, Abdel Aziz Shaheen. Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?Nutrients 2019; 11(12): 2878 doi: 10.3390/nu11122878
165
Eline H. van den Berg, Eke G. Gruppen, Sanam Ebtehaj, Stephan J.L. Bakker, Uwe J.F. Tietge, Robin P.F. Dullaart. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver diseaseAtherosclerosis 2018; 277: 21 doi: 10.1016/j.atherosclerosis.2018.07.028
166
Emir Tas, Shasha Bai, Xiawei Ou, Kelly Mercer, Haixia Lin, Kori Mansfield, Robert Buchmann, Eva C. Diaz, Jon Oden, Elisabet Børsheim, Sean H. Adams, Jonathan Dranoff. Fibroblast Growth Factor-21 to Adiponectin Ratio: A Potential Biomarker to Monitor Liver Fat in Children With ObesityFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00654
167
Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double‐blind, placebo‐controlled, clinical trialInternational Journal of Clinical Practice 2021; 75(11) doi: 10.1111/ijcp.14852
168
Francesca Oppedisano, Carolina Muscoli, Vincenzo Musolino, Cristina Carresi, Roberta Macrì, Caterina Giancotta, Francesca Bosco, Jessica Maiuolo, Federica Scarano, Sara Paone, Saverio Nucera, Maria Caterina Zito, Miriam Scicchitano, Stefano Ruga, Monica Ragusa, Ernesto Palma, Annamaria Tavernese, Rocco Mollace, Ezio Bombardelli, Vincenzo Mollace. The Protective Effect of Cynara Cardunculus Extract in Diet-Induced NAFLD: Involvement of OCTN1 and OCTN2 Transporter SubfamilyNutrients 2020; 12(5): 1435 doi: 10.3390/nu12051435
169
Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi‐Asl, Vahid Maleki. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic reviewObesity Reviews 2019; 20(7): 1057 doi: 10.1111/obr.12853
170
Rasoul Shafiezadeh, Seyed Moayed Alavian, Hasan Namdar, Mohammad Gholami-Fesharaki, Seyed Saeid Esmaeili. Evaluating the Efficacy of Carum Copticum Seeds on the Treatment of Patients with Nonalcoholic Fatty Liver Disease: A Multi-Center, Randomized, Triple–Blind, Placebo-Controlled Clinical Trial StudyHepatitis Monthly 2021; 20(12) doi: 10.5812/hepatmon.110488
171
Sophie E. Kastberg, Helene S. Lund, Emanuella Lucia‐Rolfe, Lydia U. Kaduka, Michael K. Boit, Eva Corpeleijn, Henrik Friis, Sophie Bernard, Martine Paquette, Alexis Baass, Jon J. Rasmussen, Dirk L. Christensen. Hepatic steatosis is associated with anthropometry, cardio‐metabolic disease risk, sex, age and urbanisation, but not with ethnicity in adult KenyansTropical Medicine & International Health 2022; 27(1): 49 doi: 10.1111/tmi.13696
172
Shu Liang, Yupei Zhang, Yuanjun Deng, Yifang He, Yinji Liang, Zien Liang, Yanning Chen, Kairui Tang, Runsen Chen, Qinhe Yang. The Potential Effect of Chinese Herbal Formula Hongqijiangzhi Fang in Improving NAFLD: Focusing on NLRP3 Inflammasome and Gut MicrobiotaEvidence-Based Complementary and Alternative Medicine 2018; 2018: 1 doi: 10.1155/2018/5378961
173
Ernesto Cortes, Dariusz Lachowski, Alistair Rice, Antonios Chronopoulos, Benjamin Robinson, Stephen Thorpe, David A Lee, Lucia A Possamai, Haiyun Wang, David J Pinato, Armando E. del Río Hernández. Retinoic Acid Receptor‐β Is Downregulated in Hepatocellular Carcinoma and Cirrhosis and Its Expression Inhibits Myosin‐Driven Activation and Durotaxis in Hepatic Stellate CellsHepatology 2019; 69(2): 785 doi: 10.1002/hep.30193
174
Manca Povsic, Louisa Oliver, Neha Raju Jiandani, Richard Perry, Juliana Bottomley. A structured literature review of interventions used in the management of nonalcoholic steatohepatitis ( NASH ) Pharmacology Research & Perspectives 2019; 7(3): e00485 doi: 10.1002/prp2.485
175
Samira Kazemi, Farzad Shidfar, Simin Ehsani, Peyman Adibi, Leila Janani, Omid Eslami. The effects of sumac (Rhus coriaria L.) powder supplementation in patients with non-alcoholic fatty liver disease: A randomized controlled trialComplementary Therapies in Clinical Practice 2020; 41: 101259 doi: 10.1016/j.ctcp.2020.101259
176
S. Maâlej, S. Jedidi, H. Hannachi, H. Gharsalli, I. Sahnoun, H. Neji, L. El Gharbi. Prévalence et facteurs de risque de stéatose hépatique chez les adultes tunisiens atteints de syndrome d’apnées hypopnées obstructives du sommeilRevue des Maladies Respiratoires 2020; 37(1): 8 doi: 10.1016/j.rmr.2019.11.643
177
Han Wang, Yanjun Jia, Xiaoyan Yu, Li Peng, Chunfeng Mou, Zhixin Song, Dapeng Chen, Xiaoqiang Li, Antonio Molina Carballo. Circulating Prokineticin 2 Levels Are Increased in Children with Obesity and Correlated with Insulin ResistanceInternational Journal of Endocrinology 2021; 2021: 1 doi: 10.1155/2021/6630102
178
Esteban Porrini, Maruja Navarro-Díaz, Rosa Rodríguez-Rodríguez, Eduardo Salido. Diabetic Nephropathy2019; : 65 doi: 10.1007/978-3-319-93521-8_5
179
Yoosoo Chang, Jin-Won Noh, Joo Young Cheon, Yejin Kim, Young Dae Kwon, Seungho Ryu. Self-rated health and risk of incident non-alcoholic fatty liver disease: A cohort studyScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60823-8
180
Avner Ehrlich, Sabina Tsytkin-Kirschenzweig, Konstantinos Ioannidis, Muneef Ayyash, Anne Riu, Reine Note, Gladys Ouedraogo, Jan Vanfleteren, Merav Cohen, Yaakov Nahmias. Microphysiological flux balance platform unravels the dynamics of drug induced steatosisLab on a Chip 2018; 18(17): 2510 doi: 10.1039/C8LC00357B
181
Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese ChildrenInternational Journal of Molecular Sciences 2019; 20(18): 4444 doi: 10.3390/ijms20184444
182
Pian Xiong, Yong-Fen Zhu. Soy diet for nonalcoholic fatty liver diseaseMedicine 2021; 100(22): e25817 doi: 10.1097/MD.0000000000025817
183
Tasur Kumar Seen, Muntazir Sayed, Muhammad Bilal, Jonathan Vincent Reyes, Priyanka Bhandari, Vennis Lourdusamy, Ahmed Al-khazraji, Umer Syed, Yasar Sattar, Raghav Bansal. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosisWorld Journal of Gastroenterology 2021; 27(23): 3238-3248 doi: 10.3748/wjg.v27.i23.3238
184
MoezAlIslam Faris, Haitham Jahrami, Dana Abdelrahim, Nicola Bragazzi, Ahmed BaHammam. The effects of Ramadan intermittent fasting on liver function in healthy adults: A systematic review, meta-analysis, and meta-regressionDiabetes Research and Clinical Practice 2021; 178: 108951 doi: 10.1016/j.diabres.2021.108951
185
Cameron J. Herting, Gregory B. Lesinski. Cancer Immunotherapy 2021;  doi: 10.1007/13905_2021_1
186
Damien Viglino, Anais Plazanet, Sebastien Bailly, Meriem Benmerad, Ingrid Jullian-Desayes, Renaud Tamisier, Vincent Leroy, Jean-Pierre Zarski, Maxime Maignan, Marie Joyeux-Faure, Jean-Louis Pépin. Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary DiseaseScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-34988-2
187
Isabel Hidalgo, Nayelli Nájera, Eduardo Meaney, Javier Pérez-Durán, Yolotzin Valdespino-Vazquez, Francisco Villarreal, Guillermo Ceballos. Effects of (−)-epicatechin on the time course of the expression of perilipins in a diet-induced model of nonalcoholic steatohepatitisThe Journal of Nutritional Biochemistry 2020; 77: 108296 doi: 10.1016/j.jnutbio.2019.108296
188
C. Pieterman, J. Jiang, M. Gerards, G. Ertaylan, R. Peeters, T. de Kok. P12-49 Finding the roadmap of a liver cell developing non-alcoholic fatty liver diseaseToxicology Letters 2022; 368: S194 doi: 10.1016/j.toxlet.2022.07.528
189
Seon-Heui Cha, Yongha Hwang, Soo-Jin Heo, Hee-Sook Jun. Indole-4-carboxaldehyde Isolated from Seaweed, Sargassum thunbergii, Attenuates Methylglyoxal-Induced Hepatic InflammationMarine Drugs 2019; 17(9): 486 doi: 10.3390/md17090486
190
Patrick C. Turnbull, Ali C. Dehghani, Christopher F. Theriau, Michael K. Connor, Christopher G. R. Perry. Synergistic activation of mitochondrial metabolism and the glutathione redox couple protects HepG2 hepatocarcinoma cells from palmitoylcarnitine-induced stressAmerican Journal of Physiology-Cell Physiology 2019; 317(6): C1324 doi: 10.1152/ajpcell.00366.2019
191
Yong Du, Laura Paglicawan, Sanam Soomro, Omar Abunofal, Sahar Baig, Kamala Vanarsa, John Hicks, Chandra Mohan. Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage PolarizationNutrients 2021; 13(2): 599 doi: 10.3390/nu13020599
192
Ludivine Renaud, Willian A. da Silveira, E. Starr Hazard, Jonathan Simpson, Silvia Falcinelli, Dongjun Chung, Oliana Carnevali, Gary Hardiman. The Plasticizer Bisphenol A Perturbs the Hepatic Epigenome: A Systems Level Analysis of the miRNomeGenes 2017; 8(10): 269 doi: 10.3390/genes8100269
193
Ying Wang, Chaojie Chen, Jiajun Chen, Tingting Sang, He Peng, Xiaojian Lin, Qian Zhao, Shengjia Chen, Thomas Eling, Xingya Wang. Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activationRedox Biology 2022; 52: 102322 doi: 10.1016/j.redox.2022.102322
194
Prabhakar Yellanur Konda, Vijayakumar Poondla, Krishna Kumar Jaiswal, Sreenivasulu Dasari, Reddemma Uyyala, Venkata Prasad Surtineni, Janardhan Yadav Egi, Anthony Johnson Antony Masilamani, Lakshmi Bestha, Sreenath Konanki, Muthukumaran Muthulingam, Lakshman Kumar Lingamgunta, Bindu Prasuna Aloor, Sridevi Tirumalaraju, Ankanna Sade, Venkata Ratnam Kamsala, Sreeharsha Nagaraja, Ranjani Ramakrishnan, Vijayakumar Natesan. Pathophysiology of high fat diet induced obesity: impact of probiotic banana juice on obesity associated complications and hepatosteatosisScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-73670-4
195
Hafiz Muhammad Umer Farooqi, Anupamma Sammantasinghar, Farzana Kausar, Muhammad Awais Farooqi, Abdul Rahim Chethikkattuveli Salih, Kinam Hyun, Jong-Hwan Lim, Atif Ali Khan Khalil, Abdul Samad Mumtaz, Kyung Hyun Choi. Study of the Anticancer Potential of Plant Extracts Using Liver Tumor Microphysiological SystemLife 2022; 12(2): 135 doi: 10.3390/life12020135
196
Kannan Sridharan, Gowri Sivaramakrishnan, Reginald Paul Sequeira, Abdelaziz Elamin. Pharmacological interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysisPostgraduate Medical Journal 2018; 94(1116): 556 doi: 10.1136/postgradmedj-2018-135967
197
Arya M. Sharma. Differential indications for weight lossCurrent Opinion in Endocrine and Metabolic Research 2019; 4: 58 doi: 10.1016/j.coemr.2018.09.001
198
Mariane Róvero Costa, Jéssica Leite Garcia, Carol Cristina Vágula de Almeida Silva, Artur Junio Togneri Ferron, Fabiane Valentini Francisqueti-Ferron, Fabiana Kurokawa Hasimoto, Cristina Schmitt Gregolin, Dijon Henrique Salomé de Campos, Cleverton Roberto de Andrade, Ana Lúcia dos Anjos Ferreira, Camila Renata Corrêa, Fernando Moreto. Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese RatsAntioxidants 2019; 8(8): 276 doi: 10.3390/antiox8080276
199
Enxiang Zhang, Shutao Yin, Shuang Zhao, Chong Zhao, Mingzhu Yan, Lihong Fan, Hongbo Hu. Protective effects of glycycoumarin on liver diseasesPhytotherapy Research 2020; 34(6): 1191 doi: 10.1002/ptr.6598
200
Dragana Rajcic, Anja Baumann, Angélica Hernández-Arriaga, Annette Brandt, Anika Nier, Cheng Jun Jin, Victor Sánchez, Finn Jung, Amélia Camarinha-Silva, Ina Bergheim. Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginaseRedox Biology 2021; 41: 101879 doi: 10.1016/j.redox.2021.101879
201
N.A. Rajesh, L. Drishya, Murali Mohan Raju Ambati, Athi L. Narayanan, Maria Alex, Kiran Kumar R, Justin J. Abraham, T.M. Vijayakumar. Safety and Efficacy of Saroglitazar in Nonalcoholic Fatty Liver Patients With Diabetic Dyslipidemia—A Prospective, Interventional, Pilot StudyJournal of Clinical and Experimental Hepatology 2022; 12(1): 61 doi: 10.1016/j.jceh.2021.03.012
202
Shaza Asif, Ri Youn Kim, Thet Fatica, Jordan Sim, Xiaoling Zhao, Yena Oh, Alix Denoncourt, Angela C. Cheung, Michael Downey, Erin E. Mulvihill, Kyoung-Han Kim. Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosisMolecular Metabolism 2022; 61: 101494 doi: 10.1016/j.molmet.2022.101494
203
Angelique M. L. Scantlebery, Peter Ochodnicky, Lotte Kors, Elena Rampanelli, Loes M. Butter, Chaima El Boumashouli, Nike Claessen, Gwen J. Teske, Marius A. van den Bergh Weerman, Jaklien C. Leemans, Joris J. T. H. Roelofs, Sandrine Florquin. β-Cyclodextrin counteracts obesity in Western diet-fed mice but elicits a nephrotoxic effectScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53890-z
204
Letícia Fernandes Gomes, Sibelle Aparecida Madureira Costa, Arthur Rocha-Gomes, Amanda Escobar Teixeira, Alexandre Alves da Silva, Mayara Rodrigues Lessa, Nísia Andrade Villela Dessimoni-Pinto, Sergio Ricardo Stuckert Seixas, Tania Regina Riul. Cafeteria diet from birth to adulthood promotes hepatic steatosis and redox imbalance in Wistar ratsNutrition & Food Science 2021; 51(3): 483 doi: 10.1108/NFS-05-2020-0191
205
Karla MacDonald-Ramos, Layla Michán, Alejandra Martínez-Ibarra, Marco Cerbón. Silymarin is an ally against insulin resistance: A reviewAnnals of Hepatology 2021; 23: 100255 doi: 10.1016/j.aohep.2020.08.072
206
Valerio Azzimato, Ping Chen, Emelie Barreby, Cecilia Morgantini, Laura Levi, Ana Vankova, Jennifer Jager, André Sulen, Marina Diotallevi, Joanne X. Shen, Anne Miller, Ewa Ellis, Mikael Rydén, Erik Näslund, Anders Thorell, Volker M. Lauschke, Keith M. Channon, Mark J. Crabtree, Arvand Haschemi, Siobhan M. Craige, Mattia Mori, Francesco Spallotta, Myriam Aouadi. Hepatic miR-144 Drives Fumarase Activity Preventing NRF2 Activation During ObesityGastroenterology 2021; 161(6): 1982 doi: 10.1053/j.gastro.2021.08.030
207
Daiane Costa dos Santos, Josemar Gonçalves de Oliveira Filho, Tainara Leal de Sousa, Carolina Barbosa Ribeiro, Mariana Buranelo Egea. Ameliorating effects of metabolic syndrome with the consumption of rich-bioactive compounds fruits from Brazilian Cerrado: a narrative reviewCritical Reviews in Food Science and Nutrition 2022; 62(27): 7632 doi: 10.1080/10408398.2021.1916430
208
D.H. Seo, Y.-h. Lee, S.W. Park, Y.J. Choi, B.W. Huh, E. Lee, K.B. Huh, S.H. Kim, B.-S. Cha. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetesDiabetes & Metabolism 2020; 46(5): 362 doi: 10.1016/j.diabet.2019.10.004
209
Yana Sandlers, Rohan R. Shah, Ryan W. Pearce, Jaividhya Dasarathy, Arthur J. McCullough, Srinivasan Dasarathy. Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver DiseaseJournal of Clinical Medicine 2020; 9(2): 314 doi: 10.3390/jcm9020314
210
Alessia Di Costanzo, Lucia Pacifico, Claudio Chiesa, Francesco Massimo Perla, Fabrizio Ceci, Antonio Angeloni, Laura D’Erasmo, Michele Di Martino, Marcello Arca. Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesityPediatric Research 2019; 85(5): 671 doi: 10.1038/s41390-019-0303-1
211
Luis Cano, Juan Pablo Cerapio, Eloy Ruiz, Agnès Marchio, Bruno Turlin, Sandro Casavilca, Luis Taxa, Guillaume Marti, Eric Deharo, Pascal Pineau, Stéphane Bertani. Liver clear cell foci and viral infection are associated with non-cirrhotic, non-fibrolamellar hepatocellular carcinoma in young patients from South AmericaScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28286-0
212
Maysa Ahmed Mobasher, Hala Galal El-Tantawi, Karim Samy El-Said. Metformin Ameliorates Oxidative Stress Induced by Diabetes Mellitus and Hepatocellular Carcinoma in RatsReports of Biochemistry and Molecular Biology 2020; 9(1): 115 doi: 10.29252/rbmb.9.1.115
213
Matteo Tardelli, Francesca V. Bruschi, Thierry Claudel, Claudia D. Fuchs, Nicole Auer, Victoria Kunczer, Tatjana Stojakovic, Hubert Scharnagl, Aida Habib, Gernot F. Grabner, Robert Zimmermann, Sophie Lotersztajn, Michael Trauner. Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorptionJournal of Lipid Research 2019; 60(7): 1284 doi: 10.1194/jlr.M093369
214
Jovana Milic, Valentina Menozzi, Filippo Schepis, Andrea Malagoli, Giulia Besutti, Iacopo Franconi, Alessandro Raimondi, Federica Carli, Cristina Mussini, Giada Sebastiani, Giovanni Guaraldi. Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIVAIDS 2020; 34(13): 1915 doi: 10.1097/QAD.0000000000002650
215
Laura Draijer, Marc Benninga, Bart Koot. Pediatric NAFLD: an overview and recent developments in diagnostics and treatmentExpert Review of Gastroenterology & Hepatology 2019; 13(5): 447 doi: 10.1080/17474124.2019.1595589
216
Jiayun Ge, Yannan Bai, Bo Tang, Dong Wei, Maolin Yan, Amir Radfar. The Gene Signature Associated with Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver DiseaseJournal of Oncology 2021; 2021: 1 doi: 10.1155/2021/6630535
217
Pei Xuan Song, Juan Peng, Mohyeddine Omrane, Ting ting Cai, Didier Samuel, Ama Gassama-Diagne. Septin 9 and phosphoinositides regulate lysosome localization and their association with lipid dropletsiScience 2022; 25(5): 104288 doi: 10.1016/j.isci.2022.104288
218
Wenlong Hao, Minghao Li, Qingmin Cai, Shiying Wu, Xiangyao Li, Quanyu He, Yongbin Hu. Roles of NRF2 in Fibrotic Diseases: From Mechanisms to Therapeutic ApproachesFrontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.889792
219
SHIKHA SRIVASTAVA, ZEBA SIDDIQI, TARUNA SINGH, LAKSHMI BALA. Beetroot Supplementation on Non - Alcoholic Fatty Liver Disease PatientsCurrent Research in Nutrition and Food Science Journal 2019; 7(1): 96 doi: 10.12944/CRNFSJ.7.1.10
220
Daniela Maria Tanase, Evelina Maria Gosav, Claudia Florida Costea, Manuela Ciocoiu, Cristina Mihaela Lacatusu, Minela Aida Maranduca, Anca Ouatu, Mariana Floria. The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)Journal of Diabetes Research 2020; 2020: 1 doi: 10.1155/2020/3920196
221
Fernanda Torres Quitete, Giulia Medeiros Almeida Santos, Leilson de Oliveira Ribeiro, Cristiane Aguiar da Costa, Suely Pereira Freitas, Virgínia Martins da Matta, Julio Beltrame Daleprane. Phenolic-rich smoothie consumption ameliorates non-alcoholic fatty liver disease in obesity mice by increasing antioxidant responseChemico-Biological Interactions 2021; 336: 109369 doi: 10.1016/j.cbi.2021.109369
222
Rubén Peña-Vélez, Nayely Garibay-Nieto, Manuel Cal-y-Mayor-Villalobos, Estibalitz Laresgoiti-Servitje, Karen Pedraza-Escudero, María del Carmen García-Blanco, Omar Alfonso Heredia-Nieto, Eréndira Villanueva-Ortega. Association between neck circumference and non-alcoholic fatty liver disease in Mexican children and adolescents with obesityJournal of Pediatric Endocrinology and Metabolism 2020; 33(2): 205 doi: 10.1515/jpem-2019-0204
223
Harshul Pandit, Joseph P. Tinney, Yan Li, Guozhen Cui, Suping Li, Bradley B. Keller, Robert C.G. Martin. Utilizing Contrast-Enhanced Ultrasound Imaging for Evaluating Fatty Liver Disease Progression in Pre-clinical Mouse ModelsUltrasound in Medicine & Biology 2019; 45(2): 549 doi: 10.1016/j.ultrasmedbio.2018.10.011
224
Ye Eun Cho, Yong Seong Kwon, Seonghwan Hwang. Heterogeneous population of macrophages in the development of non-alcoholic fatty liver disease☆Liver Research 2022;  doi: 10.1016/j.livres.2022.06.001
225
Luigi Aloia. Epigenetic Regulation of Cell-Fate Changes That Determine Adult Liver Regeneration After InjuryFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.643055
226
Siavash Mehdizadeh Seraj, Abdullah Al-Zaghal, Mahdi Z. Zadeh, Pegah Jahangiri, Kamyar Pournazari, William Y. Raynor, Thomas J. Werner, Poul F. Høilund-Carlsen, Abass Alavi, Stephen J. Hunt. Dynamics of fluorine-18-fluorodeoxyglucose uptake in the liver and its correlation with hepatic fat content and BMINuclear Medicine Communications 2019; 40(5): 545 doi: 10.1097/MNM.0000000000001000
227
Chih‐Yuan Ko, Yangming Martin Lo, Jian‐Hua Xu, Wen‐Chang Chang, Da‐Wei Huang, James Swi‐Bea Wu, Cho‐Hua Yang, Wen‐Chung Huang, Szu‐Chuan Shen. Alpha‐lipoic acid alleviates NAFLD and triglyceride accumulation in liver via modulating hepatic NLRP3 inflammasome activation pathway in type 2 diabetic ratsFood Science & Nutrition 2021; 9(5): 2733 doi: 10.1002/fsn3.2235
228
Yuling Xing, Tiantian Cheng, Fei Zhou, Huijuan Ma. The Association Between Vitamin D and Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease: An Observational Cross-Sectional StudyDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 269 doi: 10.2147/DMSO.S348870
229
Ju-Yeon Kim, Haena Choi, Hyeon-Ji Kim, Yelin Jee, Minsoo Noh, Mi-Ock Lee. Polyploidization of Hepatocytes: Insights into the Pathogenesis of Liver DiseasesBiomolecules & Therapeutics 2022; 30(5): 391 doi: 10.4062/biomolther.2022.070
230
Annalisa Curcio, Adriana Romano, Simona Cuozzo, Antonio Di Nicola, Orazio Grassi, Donatella Schiaroli, Giuseppe Fabrizio Nocera, Michele Pironti. Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD PatientsMedicina 2020; 56(10): 544 doi: 10.3390/medicina56100544
231
Zeynab Yousefi, Mitra Nourbakhsh, Zohreh Abdolvahabi, Seyedeh‐Sara Ghorbanhosseini, Zahra Hesari, Sahar Yarahmadi, Samira Ezzati‐Mobasser, Parvane Seiri, Mohammad Borji, Reza Meshkani, Mojtaba Malek. microRNA‐141 is associated with hepatic steatosis by downregulating the sirtuin1/AMP‐activated protein kinase pathway in hepatocytesJournal of Cellular Physiology 2020; 235(2): 880 doi: 10.1002/jcp.29002
232
Julie Rask Larsen, Lorena Dima, Christoph U. Correll, Peter Manu. The pharmacological management of metabolic syndromeExpert Review of Clinical Pharmacology 2018; 11(4): 397 doi: 10.1080/17512433.2018.1429910
233
Yanyan Wang, Xiqiao Zhou, Derrick Zhao, Xuan Wang, Emily C. Gurley, Runping Liu, Xiaojiaoyang Li, Phillip B. Hylemon, Weidong Chen, Huiping Zhou, Gianfranco D. Alpini. Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytesPLOS ONE 2020; 15(5): e0232630 doi: 10.1371/journal.pone.0232630
234
Julio Plaza-Díaz, Patricio Solis-Urra, Jerónimo Aragón-Vela, Fernando Rodríguez-Rodríguez, Jorge Olivares-Arancibia, Ana I. Álvarez-Mercado. Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and DiagnosisBiomedicines 2021; 9(2): 145 doi: 10.3390/biomedicines9020145
235
Christian S. Alvarez, Barry I. Graubard, Jake E. Thistle, Jessica L. Petrick, Katherine A. McGlynn. Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow‐upHepatology 2020; 72(2): 430 doi: 10.1002/hep.31040
236
Dariusz Narankiewicz, Josefina Ruiz-Nava, Veronica Buonaiuto, María Isabel Ruiz-Moreno, María Dolores López-Carmona, Luis Miguel Pérez-Belmonte, Ricardo Gómez-Huelgas, María Rosa Bernal-López. Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean PopulationInternational Journal of Environmental Research and Public Health 2020; 17(10): 3518 doi: 10.3390/ijerph17103518
237
A.K. Sahu, A. Upadhyay, H. Bhakuni, A.M.H.S. Attanayake, P. Sharma. Effect of Ayurveda interventions in non-alcoholic grade II fatty liver associated with obesity – A case reportJournal of Ayurveda and Integrative Medicine 2022; 13(3): 100605 doi: 10.1016/j.jaim.2022.100605
238
Ning Zhang, Yuli Wang, Junli Zhang, Beibei Liu, Guixin Li, Shengliang Xin, Keshu Xu. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in miceMolecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10316
239
Dieter Furthner, Daniel Weghuber, Christopher Dalus, Andreas Lukas, Hannah N. Stundner-Ladenhauf, Harald Mangge, Thomas Pixner. Nonalcoholic Fatty Liver Disease in Children with Obesity: Narrative Review and Research GapsHormone Research in Paediatrics 2022; 95(2): 167 doi: 10.1159/000518595
240
Luo Yang, Xiang Zhang, Min Liao, Yarong Hao. RETRACTED: Echinacoside improves diabetic liver injury by regulating the AMPK/SIRT1 signaling pathway in db/db miceLife Sciences 2021; 271: 119237 doi: 10.1016/j.lfs.2021.119237
241
Esther van Eekelen, Anouk Geelen, Marjan Alssema, Hildo J Lamb, Albert de Roos, Frits R Rosendaal, Renée de Mutsert. Sweet Snacks Are Positively and Fruits and Vegetables Are Negatively Associated with Visceral or Liver Fat Content in Middle-Aged Men and WomenThe Journal of Nutrition 2019; 149(2): 304 doi: 10.1093/jn/nxy260
242
René R. Balandrán-Quintana, Ana María Mendoza-Wilson. Bioactive Molecules in FoodReference Series in Phytochemistry 2019; : 295 doi: 10.1007/978-3-319-78030-6_57
243
Janna C. Nawroth, Debora B. Petropolis, Dimitris V. Manatakis, Tengku Ibrahim Maulana, Gabriel Burchett, Katharina Schlünder, Anke Witt, Abhishek Shukla, Konstantia Kodella, Janey Ronxhi, Gauri Kulkarni, Geraldine Hamilton, Ekihiro Seki, Shelly Lu, Katia C. Karalis. Modeling alcohol-associated liver disease in a human Liver-ChipCell Reports 2021; 36(3): 109393 doi: 10.1016/j.celrep.2021.109393
244
Katherine Rodriguez, Ashley Cast, Nikolai A. Timchenko. Correction of aging phenotype in the liverAging 2018; 10(8): 1795 doi: 10.18632/aging.101523
245
Ping Ye, Jijun Liu, Wuping Xu, Denghai Liu, Xiangchao Ding, Sheng Le, Hao Zhang, Shanshan Chen, Manhua Chen, Jiahong Xia. Dual‐Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta–Activated Kinase 1 SuppressionHepatology 2019; 69(5): 1946 doi: 10.1002/hep.30485
246
Siân P Cartland, Nicole Tamer, Manisha S Patil, Belinda A Di Bartolo, Mary M Kavurma. A “Western Diet” promotes symptoms of hepatic steatosis in spontaneously hypertensive ratsInternational Journal of Experimental Pathology 2020; 101(5): 152 doi: 10.1111/iep.12369
247
Yunjie Liao, Nathan A. Davies, I. David L. Bogle. A process systems Engineering approach to analysis of fructose consumption in the liver system and consequences for Non-Alcoholic fatty liver diseaseChemical Engineering Science 2022; 263: 118131 doi: 10.1016/j.ces.2022.118131
248
Cíntia Castro-Correia, Rita Santos-Silva, Marta Pinheiro, Carla Costa, Manuel Fontoura. Metabolic risk factors in adolescent girls with type 1 diabetesJournal of Pediatric Endocrinology and Metabolism 2018; 31(6): 631 doi: 10.1515/jpem-2018-0053
249
Nilay D. Solanki, Kirti Vadi, Sandip Patel. Alleviating effect of Ficus racemosa in high-fat-high-fructose diet-induced non-alcoholic fatty liver diseaseIndian Journal of Physiology and Pharmacology 2021; 65: 12 doi: 10.25259/IJPP_406_2020
250
A. V. Bogolyubova, E. E. Mishina, P. O. Bogomolov, M. V. Matsievich, K. Yu. Kokina, A. Yu. Mayorov, P. V. Belousov. EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTSMedical Immunology (Russia) 2019; 21(5): 945 doi: 10.15789/1563-0625-2019-5-945-952
251
Xiaolei Zhang, Xueying Shang, Shi Jin, Zhuoqi Ma, He Wang, Na AO, Jing Yang, Jian Du. Vitamin D ameliorates high-fat-diet-induced hepatic injury via inhibiting pyroptosis and alters gut microbiota in ratsArchives of Biochemistry and Biophysics 2021; 705: 108894 doi: 10.1016/j.abb.2021.108894
252
Hui-Ting Chen, Hong-Li Huang, Yong-Qiang Li, Hao-Ming Xu, Yong-Jian Zhou. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered viewWorld Journal of Gastroenterology 2020; 26(16): 1901-1911 doi: 10.3748/wjg.v26.i16.1901
253
David E. Stec, Darren M. Gordon, Jennifer A. Hipp, Stephen Hong, Zachary L. Mitchell, Natalia R. Franco, J. Walker Robison, Christopher D. Anderson, Donald F. Stec, Terry D. Hinds. Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesityAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2019; 317(5): R733 doi: 10.1152/ajpregu.00153.2019
254
Tianhao Zhou, Debjyoti Kundu, Jonathan Robles-Linares, Vik Meadows, Keisaku Sato, Leonardo Baiocchi, Burcin Ekser, Shannon Glaser, Gianfranco Alpini, Heather Francis, Lindsey Kennedy. Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver DiseaseCells 2021; 10(8): 2072 doi: 10.3390/cells10082072
255
Magdy M. Youssef, Amal Elshaer, Rizk Elbaz, Yehia A. Ellazek, Ahmad El-Waseef, Ahmad Settin. ApolipoproteinC3 Gene Variants in Nonalcoholic Fatty Liver Disease in EgyptAmerican Journal of Biochemistry and Molecular Biology 2017; 8(1): 16 doi: 10.3923/ajbmb.2018.16.22
256
Md Akheruzzaman, Vijay Hegde, Andrew C. Shin, Nikhil V. Dhurandhar. Reducing endogenous insulin is linked with protection against hepatic steatosis in miceNutrition & Diabetes 2020; 10(1) doi: 10.1038/s41387-020-0114-9
257
Tomislav Mašek, Josip Barišić, Vedran Micek, Kristina Starčević. Cafeteria Diet and High-Fructose Rodent Models of NAFLD Differ in the Metabolism of Important PUFA and Palmitoleic Acid without Additional Influence of SexNutrients 2020; 12(11): 3339 doi: 10.3390/nu12113339
258
Sok Kuan Wong, Kok-Yong Chin, Fairus Ahmad, Soelaiman Ima-Nirwana. Regulation of inflammatory response and oxidative stress by tocotrienol in a rat model of non-alcoholic fatty liver diseaseJournal of Functional Foods 2020; 74: 104209 doi: 10.1016/j.jff.2020.104209
259
Bo Wang, Yanghua Qu, Yiping Wang, Yong Ma, Chenchen Xu, Fadi Li, Ce Liu, Xiaonan Lu, Bo Wang, Peng Xiu, Yuefeng Gao, Zhicheng Diao, Yuxia Li, Hailing Luo. Triplet Male Lambs Are More Susceptible than Twins to Dietary Soybean Oil–Induced Fatty LiverThe Journal of Nutrition 2019; 149(6): 989 doi: 10.1093/jn/nxz039
260
Yvonne Huber, Jörn M. Schattenberg. Nicht-alkoholische Fettlebererkrankung2022; : 1 doi: 10.1007/978-3-662-62484-5_1
261
Simona Todisco, Anna Santarsiero, Paolo Convertini, Giulio De Stefano, Michele Gilio, Vito Iacobazzi, Vittoria Infantino. PPAR Alpha as a Metabolic Modulator of the Liver: Role in the Pathogenesis of Nonalcoholic Steatohepatitis (NASH)Biology 2022; 11(5): 792 doi: 10.3390/biology11050792
262
Adryana Cordeiro, Raquel Costa, Nelson Andrade, Cláudia Silva, Natalia Canabrava, Maria João Pena, Ilda Rodrigues, Sara Andrade, Andrea Ramalho. Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity?Clinics and Research in Hepatology and Gastroenterology 2020; 44(4): 394 doi: 10.1016/j.clinre.2019.10.001
263
Yadi Li, Yan Yang, Yufang Li, Ping Zhang, Gaiying Ge, Jing Jin, Ting Du, Maiyan Ma, Li Na, Lu Ding, Huiping Sheng. Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosisJournal of International Medical Research 2021; 49(11): 030006052110553 doi: 10.1177/03000605211055378
264
Homayoon BASHIRI, Arezoo BOZORGOMID, Vahid SHOJAEIMOTLAGH. Efficacy of Hijamat (wet cupping therapy) in Iranian patients with nonalcoholic fatty liver disease: a controlled clinical trialTURKISH JOURNAL OF MEDICAL SCIENCES 2020; 44(2): 354 doi: 10.3906/sag-1907-82
265
P. Vineeth Daniel, Surbhi Dogra, Priya Rawat, Abhinav Choubey, Aiysha Siddiq Khan, Sangam Rajak, Mohan Kamthan, Prosenjit Mondal. NF-κB p65 regulates hepatic lipogenesis by promoting nuclear entry of ChREBP in response to a high carbohydrate dietJournal of Biological Chemistry 2021; 296: 100714 doi: 10.1016/j.jbc.2021.100714
266
Lucija Virović-Jukić, Jelena Forgač, Doris Ogresta, Tajana Filipec-Kanižaj, Anna Mrzljak. Gastrointestinal Complications of DiabetesClinical Gastroenterology 2018; : 275 doi: 10.1007/978-3-319-75856-5_21
267
Eline H. van den Berg, James P. Corsetti, Stephan J. L. Bakker, Robin P. F. Dullaart, Petter Bjornstad. Plasma ApoE elevations are associated with NAFLD: The PREVEND StudyPLOS ONE 2019; 14(8): e0220659 doi: 10.1371/journal.pone.0220659
268
Ilona Darlyuk-Saadon, Chen Bai, Chew Kiat Matthew Heng, Nechama Gilad, Wei-Ping Yu, Pei Yen Lim, Amaury Cazenave-Gassiot, Yongliang Zhang, W. S. Fred Wong, David Engelberg. Active p38α causes macrovesicular fatty liver in miceProceedings of the National Academy of Sciences 2021; 118(14) doi: 10.1073/pnas.2018069118
269
Waqas B. Khalid, Nadim Farhat, Linda Lavery, Josh Jarnagin, James P. Delany, Kang Kim. Non-invasive Assessment of Liver Fat in ob/ob Mice Using Ultrasound-Induced Thermal Strain Imaging and Its Correlation with Hepatic Triglyceride ContentUltrasound in Medicine & Biology 2021; 47(4): 1067 doi: 10.1016/j.ultrasmedbio.2020.12.014
270
Muhammad Amir, Michael Yu, Peijian He, Shanthi Srinivasan. Hepatic Autonomic Nervous System and Neurotrophic Factors Regulate the Pathogenesis and Progression of Non-alcoholic Fatty Liver DiseaseFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00062
271
Alexander Myint. Improvement of liver function and glycemic control with Combination of DPP-4 inhibitors and GLP-1 agonists in type II diabetes mellitus patients with non-alcoholic steatohepatitisGastroenterology & Hepatology: Open Access 2020; 11(3): 127 doi: 10.15406/ghoa.2020.11.00427
272
Resham Ramkissoon, Timothy B. Gardner. Pancreatic Steatosis: An Emerging Clinical EntityAmerican Journal of Gastroenterology 2019; 114(11): 1726 doi: 10.14309/ajg.0000000000000262
273
Alessia Di Costanzo, Francesca Belardinilli, Diego Bailetti, Marialuisa Sponziello, Laura D’Erasmo, Licia Polimeni, Francesco Baratta, Daniele Pastori, Fabrizio Ceci, Anna Montali, Gabriella Girelli, Bruna De Masi, Antonio Angeloni, Giuseppe Giannini, Maria Del Ben, Francesco Angelico, Marcello Arca. Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing StrategyScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-21939-0
274
Venkat R. Pannala, Shanea K. Estes, Mohsin Rahim, Irina Trenary, Tracy P. O’Brien, Chiyo Shiota, Richard L. Printz, Jaques Reifman, Masakazu Shiota, Jamey D. Young, Anders Wallqvist. Toxicant-Induced Metabolic Alterations in Lipid and Amino Acid Pathways Are Predictive of Acute Liver Toxicity in RatsInternational Journal of Molecular Sciences 2020; 21(21): 8250 doi: 10.3390/ijms21218250
275
Christopher J. Schmoyer, Mohammad S. Siddiqui. Non-alcoholic Fatty Liver Disease in Non-obese PatientsCurrent Hepatology Reports 2017; 16(4): 382 doi: 10.1007/s11901-017-0377-3
276
Nuria Perez-Diaz-del-Campo, Itziar Abete, Irene Cantero, Bertha Araceli Marin-Alejandre, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jose I. Riezu-Boj, Fermín I. Milagro, Josep A. Tur, J. Alfredo Martinez, M. Angeles Zulet. Association of the SH2B1 rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver DiseaseNutrients 2020; 12(5): 1260 doi: 10.3390/nu12051260
277
Yuta Matsubara, Hiroki Kiyohara, Toshiaki Teratani, Yohei Mikami, Takanori Kanai. Organ and brain crosstalk: The liver-brain axis in gastrointestinal, liver, and pancreatic diseasesNeuropharmacology 2022; 205: 108915 doi: 10.1016/j.neuropharm.2021.108915
278
Maria Kalogirou, Emmanouil Sinakos. Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?World Journal of Hepatology 2018; 10(11): 790-794 doi: 10.4254/wjh.v10.i11.790
279
Anirudh Kohli. Is it important to quantify hepatic fibrosis?Indian Journal of Radiology and Imaging 2019; 29(04): 341 doi: 10.4103/ijri.IJRI_521_19
280
Courtney D. McGinnis, Erin Q. Jennings, Peter S. Harris, James J. Galligan, Kristofer S. Fritz. Biochemical Mechanisms of Sirtuin-Directed Protein Acylation in Hepatic Pathologies of Mitochondrial DysfunctionCells 2022; 11(13): 2045 doi: 10.3390/cells11132045
281
Yu Seol Lee, Jeong Su Park, Da Hyun Lee, Dong-Kyu Lee, Sung Won Kwon, Byung-Wan Lee, Soo Han Bae. The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 InhibitionFrontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00539
282
Nicolás Salva-Pastor, Norberto C. Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver diseaseThe Journal of Steroid Biochemistry and Molecular Biology 2019; 194: 105445 doi: 10.1016/j.jsbmb.2019.105445
283
Gonçalo Martins Pereira, Sofia S. Pereira, Madalena Santos, José Brito, Diamantino Freitas, António Oliveira de Carvalho, Artur Águas, Maria João Oliveira, Pedro Oliveira. Effects of high-intensity infrasound on liver lipid content of ratsHeliyon 2020; 6(7): e04383 doi: 10.1016/j.heliyon.2020.e04383
284
Nahum Mendez-Sanchez, Vania Cruz-Ramon, Oscar Ramirez-Perez, Jessica Hwang, Beatriz Barranco-Fragoso, Jaqueline Cordova-Gallardo. New Aspects of Lipotoxicity in Nonalcoholic SteatohepatitisInternational Journal of Molecular Sciences 2018; 19(7): 2034 doi: 10.3390/ijms19072034
285
Sarthak Sahoo, Divyoj Singh, Priyanka Chakraborty, Mohit Kumar Jolly. Emergent Properties of the HNF4α-PPARγ Network May Drive Consequent Phenotypic Plasticity in NAFLDJournal of Clinical Medicine 2020; 9(3): 870 doi: 10.3390/jcm9030870
286
Elham Karimi-Sales, Gisou Mohaddes, Mohammad Reza Alipour. Hepatoprotection of capsaicin in alcoholic and non-alcoholic fatty liver diseasesArchives of Physiology and Biochemistry 2021; : 1 doi: 10.1080/13813455.2021.1962913
287
Simone Carotti, Katia Aquilano, Francesco Valentini, Sergio Ruggiero, Francesca Alletto, Sergio Morini, Antonio Picardi, Raffaele Antonelli-Incalzi, Daniele Lettieri-Barbato, Umberto Vespasiani-Gentilucci. An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipaseAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 319(4): G469 doi: 10.1152/ajpgi.00049.2020
288
Wen-Chung Huang, Ya-Ling Chen, Hui-Chia Liu, Shu-Ju Wu, Chian-Jiun Liou. Ginkgolide C reduced oleic acid-induced lipid accumulation in HepG2 cellsSaudi Pharmaceutical Journal 2018; 26(8): 1178 doi: 10.1016/j.jsps.2018.07.006
289
Zaida Zainal, Huzwah Khaza'ai, Ammu Kutty Radhakrishnan, Sui Kiat Chang. Therapeutic potential of palm oil vitamin E-derived tocotrienols in inflammation and chronic diseases: Evidence from preclinical and clinical studiesFood Research International 2022; 156: 111175 doi: 10.1016/j.foodres.2022.111175
290
Sandra Steensels, Jixuan Qiao, Baran A. Ersoy. Transcriptional Regulation in Non-Alcoholic Fatty Liver DiseaseMetabolites 2020; 10(7): 283 doi: 10.3390/metabo10070283
291
Mark G. Swain, David E. J. Jones. Fatigue in chronic liver disease: New insights and therapeutic approachesLiver International 2019; 39(1): 6 doi: 10.1111/liv.13919
292
Fatemeh Naeini, Zahra Namkhah, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh-Attar. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver DiseaseAdvances in Nutrition 2021; 12(2): 413 doi: 10.1093/advances/nmaa106
293
Camilo Rey-Bedon, Peony Banik, Aslihan Gokaltun, O. Hofheinz, Martin.L. Yarmush, M. Korkut Uygun, O. Berk Usta. CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liverBiomedicine & Pharmacotherapy 2022; 146: 112377 doi: 10.1016/j.biopha.2021.112377
294
Dey Parama, Sosmitha Girisa, Elina Khatoon, Aviral Kumar, Mohammed S. Alqahtani, Mohamed Abbas, Gautam Sethi, Ajaikumar B. Kunnumakkara. An overview of the pharmacological activities of scopoletin against different chronic diseasesPharmacological Research 2022; 179: 106202 doi: 10.1016/j.phrs.2022.106202
295
Roberta Forlano, Mathuri Sivakumar, Benjamin H. Mullish, Pinelopi Manousou. Gut Microbiota—A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic ReviewInternational Journal of Molecular Sciences 2022; 23(15): 8307 doi: 10.3390/ijms23158307
296
Helda Tutunchi, Majid Mobasseri, Naser Aghamohammadzadeh, Jalil Hooshyar, Fatemeh Naeini, Farzad Najafipour. Serum neuregulin 4 (NRG‐4) level and non‐alcoholic fatty liver disease (NAFLD): A case‐control studyInternational Journal of Clinical Practice 2021; 75(10) doi: 10.1111/ijcp.14555
297
Katarzyna Kozłowska-Petriczko, Ewa Wunsch, Jan Petriczko, Wing-Kin Syn, Piotr Milkiewicz. Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as ReferenceJournal of Clinical Medicine 2021; 10(7): 1507 doi: 10.3390/jcm10071507
298
René R. Balandrán-Quintana, Ana María Mendoza-Wilson. SweetenersReference Series in Phytochemistry 2018; : 1 doi: 10.1007/978-3-319-54528-8_57-1
299
Lucas Zangerolamo, Gabriela Moreira Soares, Jean Franciesco Vettorazzi, Maria Esméria do Amaral, Everardo Magalhães Carneiro, Sara Teresinha Olalla-Saad, Antonio Carlos Boschero, Helena Cristina Barbosa-Sampaio. ARHGAP21 deficiency impairs hepatic lipid metabolism and improves insulin signaling in lean and obese miceCanadian Journal of Physiology and Pharmacology 2019; 97(11): 1018 doi: 10.1139/cjpp-2018-0691
300
Qian Zhang, Kun Yu, Yazhen Cao, Yanli Luo, Yan Liu, Caiyan Zhao. miR-125b promotes the NF-κB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3Life Sciences 2021; 270: 119071 doi: 10.1016/j.lfs.2021.119071
301
Yang-Hsiang Lin, Meng-Han Wu, Ya-Hui Huang, Chau-Ting Yeh, Kwang-Huei Lin. TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular CarcinomaCells 2020; 9(2): 262 doi: 10.3390/cells9020262
302
Alina Abdolahi, Zakaria Vahabzadeh, Esmael Izadpanah, Mohammad Raman Moloudi. Vaspin attenuates steatosis-induced fibrosis via GRP78 receptor by targeting AMPK signaling pathwayJournal of Physiology and Biochemistry 2022; 78(1): 185 doi: 10.1007/s13105-021-00852-7
303
Maja Ðanić, Bojan Stanimirov, Nebojša Pavlović, Svetlana Goločorbin-Kon, Hani Al-Salami, Karmen Stankov, Momir Mikov. Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic SyndromeFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01382
304
Berangere Gapp, Marie Jourdain, Pauline Bringer, Benjamin Kueng, Delphine Weber, Arnaud Osmont, Stefan Zurbruegg, Judith Knehr, Rocco Falchetto, Guglielmo Roma, William Dietrich, Reginald Valdez, Nicolau Beckmann, Florian Nigsch, Arun J. Sanyal, Iwona Ksiazek. Farnesoid X Receptor Agonism, Acetyl‐Coenzyme A Carboxylase Inhibition, and Back Translation of Clinically Observed Endpoints of De Novo Lipogenesis in a Murine NASH Model Hepatology Communications 2020; 4(1): 109 doi: 10.1002/hep4.1443
305
Ji-Youn Kim, Gyu-Na Lee, Hyun Chul Song, Yong-Moon Park, Yu-Bae Ahn, Kyungdo Han, Seung-Hyun Ko. Association between Fatty Liver Index and Periodontitis: the Korea National Health and Nutrition Examination SurveyScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60797-7
306
Ceri‐Anne E. Suurmond, Soufian Lasli, Floor W. Dolder, Aly Ung, Han‐Jun Kim, Praveen Bandaru, KangJu Lee, Hyun‐Jong Cho, Samad Ahadian, Nureddin Ashammakhi, Mehmet R. Dokmeci, Junmin Lee, Ali Khademhosseini. In Vitro Human Liver Model of Nonalcoholic Steatohepatitis by Coculturing Hepatocytes, Endothelial Cells, and Kupffer CellsAdvanced Healthcare Materials 2019; 8(24): 1901379 doi: 10.1002/adhm.201901379
307
Amir Mohammad Kazemifar, Ali Akbar Shafikhani, Elaheh HajiNoormohammadi, Zahra Azarion, Aliakbar Hajiaghamohammadi. Investigating effect of Helicobacter pylori treatment on improvement of non-alcoholic fatty liver parameters: a randomized trialEgyptian Liver Journal 2019; 9(1) doi: 10.1186/s43066-019-0001-z
308
S.M. Touhidul Islam, Jeseong Won, Mushfiquddin Khan, Kenneth D. Chavin, Inderjit Singh. Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitisAnnals of Hepatology 2020; 19(5): 466 doi: 10.1016/j.aohep.2019.11.007
309
Jonathan B. Steinman, Marcela A. Salomao, Utpal B. Pajvani. Zonation in NASH – A key paradigm for understanding pathophysiology and clinical outcomesLiver International 2021; 41(11): 2534 doi: 10.1111/liv.15025
310
Aurora Barberá, Imma Raurell, Teresa García‐Lezana, Manuel Torres‐Arauz, Miren Bravo, Diana Hide, Mar Gil, María Teresa Salcedo, Joan Genescà, María Martell, Salvador Augustin. Steatosis as main determinant of portal hypertension through a restriction of hepatic sinusoidal area in a dietary rat nash modelLiver International 2020; 40(11): 2732 doi: 10.1111/liv.14632
311
Shenzong Rao, Jingsong Huang, Zhijun Shen, Changgang Xiang, Min Zhang, Xueliang Lu. Inhibition of TREM‐1 attenuates inflammation and lipid accumulation in diet‐induced nonalcoholic fatty liver diseaseJournal of Cellular Biochemistry 2019; 120(7): 11867 doi: 10.1002/jcb.28468
312
Golnaz Ranjbar, Dimitri P. Mikhailidis, Amirhossein Sahebkar. Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!Metabolism 2019; 101: 154001 doi: 10.1016/j.metabol.2019.154001
313
Sofía Montemayor, Catalina M. Mascaró, Lucía Ugarriza, Miguel Casares, Cristina Gómez, J. Alfredo Martínez, Josep A. Tur, Cristina Bouzas. Intrahepatic Fat Content and COVID-19 Lockdown in Adults with NAFLD and Metabolic SyndromeNutrients 2022; 14(17): 3462 doi: 10.3390/nu14173462
314
M. Bellan, M. Menegatti, C. Ferrari, G.P. Carnevale Schianca, M. Pirisi. Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practiceNutrition, Metabolism and Cardiovascular Diseases 2018; 28(6): 610 doi: 10.1016/j.numecd.2018.01.006
315
Cyriac Abby Philips, Philip Augustine, Rizwan Ahamed, Sasidharan Rajesh, Tom George, Sandeep Kumbar, Guruprasad Padsalgi, Pushpa Mahadevan. Acute exacerbated severe form of nonalcoholic steatohepatitis leading to acute-on-chronic liver failure: A case seriesIndian Journal of Gastroenterology 2020; 39(1): 97 doi: 10.1007/s12664-020-01028-9
316
Diego Nocetti, Alejandra Espinosa, Francisco Pino-De la Fuente, Camila Sacristán, José Luis Bucarey, Paulina Ruiz, Rodrigo Valenzuela, Raphaël Chouinard-Watkins, Inés Pepper, Rodrigo Troncoso, Luis Puente. Lipid droplets are both highly oxidized and Plin2-covered in hepatocytes of diet-induced obese miceApplied Physiology, Nutrition, and Metabolism 2020; 45(12): 1368 doi: 10.1139/apnm-2019-0966
317
Razk Abdalgwad, Mohammed Faraz Rafey, Conor Murphy, Iulia Ioana, Paula Mary O’Shea, Eoin Slattery, Colin Davenport, Derek Timothy O’Keeffe, Francis Martin Finucane. Changes in alanine aminotransferase in adults with severe and complicated obesity during a milk-based meal replacement programmeNutrition & Metabolism 2020; 17(1) doi: 10.1186/s12986-020-00512-5
318
Huili Yang, Lian Feng, Linyi Xu, Dansheng Jiang, Fenfen Zhai, Guangdong Tong, Yufeng Xing, Koichiro Wada. Intervention of Shugan Xiaozhi Decoction on Nonalcoholic Fatty Liver Disease via Mediating Gut-Liver AxisBioMed Research International 2022; 2022: 1 doi: 10.1155/2022/4801695
319
Tapan Behl, Ishnoor Kaur, Aayush Sehgal, Sukhbir Singh, Gokhan Zengin, Nicoleta Negrut, Delia Carmen Nistor-Cseppento, Flavia Maria Pavel, Raluca Anca Corb Aron, Simona Bungau. Exploring the Genetic Conception of Obesity via the Dual Role of FoxOInternational Journal of Molecular Sciences 2021; 22(6): 3179 doi: 10.3390/ijms22063179
320
Imran Nazir Salroo, Musharaf Bashir, Rayees Ahmad Bhat, Sheikh Imran Sayeed, Nazir Ahmad Salroo. Correlates of ultrasound diagnosed non alcoholic fatty liver disease in Indian adults with features of metabolic syndromeJournal of Clinical Medicine of Kazakhstan 2020; 1(55): 17 doi: 10.23950/1812-2892-JCMK-00732
321
Luis Fontana, Julio Plaza-Díaz, Paula Robles-Bolívar, Héctor Valente-Godínez, María José Sáez-Lara, Francisco Abadía-Molina, Carolina Gómez-Llorente, Ángel Gil, Ana I. Álvarez-Mercado. Bifidobacterium breve CNCM I-4035, Lactobacillus paracasei CNCM I-4034 and Lactobacillus rhamnosus CNCM I-4036 Modulate Macrophage Gene Expression and Ameliorate Damage Markers in the Liver of Zucker-Leprfa/fa RatsNutrients 2021; 13(1): 202 doi: 10.3390/nu13010202
322
Sarah Da Won Bae, Jacob George, Liang Qiao. From MAFLD to hepatocellular carcinoma and everything in betweenChinese Medical Journal 2022; 135(5): 547 doi: 10.1097/CM9.0000000000002089
323
Daniel R. Ludwig, Tyler J. Fraum, Roberto Cannella, Richard Tsai, Muhammad Naeem, Maverick LeBlanc, Amber Salter, Allan Tsung, Jaquelyn Fleckenstein, Anup S. Shetty, Amir A. Borhani, Alessandro Furlan, Kathryn J. Fowler. Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteriaHPB 2019; 21(12): 1697 doi: 10.1016/j.hpb.2019.04.007
324
Martín Alonso Gómez Zuleta, Oscar Fernando Ruíz Morales, Eddy Johanna Buitrago Laguado. Utilidad del índice de fibrosis hepática (IFH) medido durante la ultrasonografía endoscópica en la evaluación del parénquima pancreáticoRevista colombiana de Gastroenterología 2022; 37(1): 10 doi: 10.22516/25007440.644
325
Panagiotis Theofilis, Aikaterini Vordoni, Nikolaos Nakas, Rigas G. Kalaitzidis. Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisLife 2022; 12(5): 718 doi: 10.3390/life12050718
326
Michelle Saoi, Kazunori Sasaki, Hitoshi Sagawa, Kaori Abe, Tomomi Kogiso, Katsutoshi Tokushige, Etsuko Hashimoto, Yoshiaki Ohashi, Philip Britz-McKibbin. High Throughput Screening of Serum γ-Glutamyl Dipeptides for Risk Assessment of Nonalcoholic Steatohepatitis with Impaired Glutathione Salvage PathwayJournal of Proteome Research 2020; 19(7): 2689 doi: 10.1021/acs.jproteome.9b00405
327
M. Serdarova, R. Dimova, N. Chakarova, G. Grozeva, A. Todorova, P. Tsarkova, C. Marinova, D. Popov, L. Mateva, T. Tankova. Metabolic determinants of NAFLD in adults with type 1 diabetesDiabetes Research and Clinical Practice 2022; 186: 109819 doi: 10.1016/j.diabres.2022.109819
328
George V. Dedoussis, Athina I. Amanatidou. NAFLD and NASH2020; : 181 doi: 10.1007/978-3-030-37173-9_10
329
Victor Enrique Sarmiento-Ortega, Diana Moroni-González, Alfonso Díaz, Brambila Eduardo, Treviño Samuel. Oral Subacute Exposure to Cadmium LOAEL Dose Induces Insulin Resistance and Impairment of the Hormonal and Metabolic Liver-Adipose Axis in Wistar RatsBiological Trace Element Research 2022; 200(10): 4370 doi: 10.1007/s12011-021-03027-z
330
Yi-Hsien Chang, Ya-Ling Chen, Wen-Chung Huang, Chian-Jiun Liou. Fucoxanthin attenuates fatty acid-induced lipid accumulation in FL83B hepatocytes through regulated Sirt1/AMPK signaling pathwayBiochemical and Biophysical Research Communications 2018; 495(1): 197 doi: 10.1016/j.bbrc.2017.11.022
331
Igor V. Maev, Alexey A. Samsonov, Leonid B. Lazebnik, Elena V. Golovanova, Chavdar S. Pavlov, Elena I. Vovk, Vlad Ratziu, Kirill M. Starostin. A New, Non-Invasive Scale for Steatosis Developed Using Real-World Data From Russian Outpatients to Aid in the Diagnosis of Non-Alcoholic Fatty Liver DiseaseAdvances in Therapy 2020; 37(11): 4627 doi: 10.1007/s12325-020-01493-w
332
Nikhil Makhija, Naval K. Vikram, Deep N. Srivastava, Kumble S. Madhusudhan. Role of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis and Grading of Hepatic Steatosis in Patients With Non-alcoholic Fatty Liver Disease: Comparison With Ultrasonography and Magnetic Resonance SpectroscopyJournal of Clinical and Experimental Hepatology 2021; 11(6): 654 doi: 10.1016/j.jceh.2021.02.008
333
Maria Irene Bellini, Irene Urciuoli, Giovanni Del Gaudio, Giorgia Polti, Giovanni Iannetti, Elena Gangitano, Eleonora Lori, Carla Lubrano, Vito Cantisani, Salvatore Sorrenti, Vito D’Andrea. Nonalcoholic fatty liver disease and diabetesWorld Journal of Diabetes 2022; 13(9): 668-682 doi: 10.4239/wjd.v13.i9.668
334
Dixa Sharma, Palash Mandal. NAFLD: genetics and its clinical implicationsClinics and Research in Hepatology and Gastroenterology 2022; 46(9): 102003 doi: 10.1016/j.clinre.2022.102003
335
Muhammad Farooq, Huma Hameed, Marie-Thérèse Dimanche-Boitrel, Claire Piquet-Pellorce, Michel Samson, Jacques Le Seyec. Switching to Regular Diet Partially Resolves Liver Fibrosis Induced by High-Fat, High-Cholesterol Diet in MiceNutrients 2022; 14(2): 386 doi: 10.3390/nu14020386
336
Yue Xiong, Yan Chen, Xinping Huang, Zhen Yang, Jiaye Zhang, Xiaorui Yu, Ji Fang, Jiawang Tao, Kai You, Ziqi Cheng, Shenglin Tan, Yingying Xu, Fang Yuan, Ying Liu, Yuanqi Zhuang, Fan Yang, Yinxiong Li. Icaritin ameliorates hepatic steatosis via promoting fatty acid β-oxidation and insulin sensitivityLife Sciences 2021; 268: 119000 doi: 10.1016/j.lfs.2020.119000
337
Nehal Mohamed Bahgat Gamil, Sahar Mohamed El Agaty, Gehan Khalaf Megahed, Rania Salah Mansour, Marwa Saad Abdel-Latif. Reversion to regular diet with alternate day fasting can cure grade-I non-alcoholic fatty liver disease (NAFLD) in high-fructose-intake-associated metabolic syndromeEgyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00128-1
338
Hyeon Ju Kim, Yoseob Lee, Sungsoon Fang, Won Kim, Hyo Jung Kim, Jae-woo Kim. GPx7 ameliorates non-alcoholic steatohepatitis by regulating oxidative stressBMB Reports 2020; 53(6): 317 doi: 10.5483/BMBRep.2020.53.6.280
339
Cristina Oana Mărginean, Lorena Elena Meliț, Maria Oana Săsăran. Metabolic Associated Fatty Liver Disease in Children—From Atomistic to HolisticBiomedicines 2021; 9(12): 1866 doi: 10.3390/biomedicines9121866
340
Fajar Dwi Astarini, Neneng Ratnasari, Widya Wasityastuti. Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative ReviewIranian Biomedical Journal 2022; 26(4): 252 doi: 10.52547/ibj.3647
341
Karlijn J. Nass, Eline H. van den Berg, Eke G. Gruppen, Robin P. F. Dullaart. Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver diseaseEuropean Journal of Clinical Investigation 2018; 48(9): e12988 doi: 10.1111/eci.12988
342
Yao Teng, Zixuan Zhao, Farah Tasnim, Xiaozhong Huang, Hanry Yu. A scalable and sensitive steatosis chip with long-term perfusion of in situ differentiated HepaRG organoidsBiomaterials 2021; 275: 120904 doi: 10.1016/j.biomaterials.2021.120904
343
Jona T. Stahmeyer, Melissa Hemmerling, Birte Burger, Sveja Eberhard, Christian Krauth, Jan Zeidler, Annika Herr, Henning Weseloh, Siegbert Rossol. Die Häufigkeit von diagnostizierten Fettlebererkrankungen (NAFLD) in der deutschen Bevölkerung – Eine Analyse auf der Basis von GKV-RoutinedatenZeitschrift für Gastroenterologie 2021; 59(08): 851 doi: 10.1055/a-1402-1263
344
Ayesha Monga Kravetz, Todd Testerman, Brittany Galuppo, Joerg Graf, Bridget Pierpont, Stephan Siebel, Richard Feinn, Nicola Santoro. Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese YouthThe Journal of Clinical Endocrinology & Metabolism 2020; 105(10): e3575 doi: 10.1210/clinem/dgaa382
345
Wenqian Xu, Hongkang Zhu, Bin Hu, Yuliang Cheng, Yahui Guo, Weirong Yao, He Qian. Echinacea in hepatopathy: A review of its phytochemistry, pharmacology, and safetyPhytomedicine 2021; 87: 153572 doi: 10.1016/j.phymed.2021.153572
346
Jeong-An Gim, Soo Min Bang, Young-Sun Lee, Yoonseok Lee, Sun Young Yim, Young Kul Jung, Hayeon Kim, Baek-Hui Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun, Matias A. Avila. Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expressionPLOS ONE 2021; 16(8): e0255822 doi: 10.1371/journal.pone.0255822
347
Junli Zhang, Haiming Zhang, Xiaoling Deng, Ning Zhang, Beibei Liu, Shengliang Xin, Guixin Li, Keshu Xu. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in miceLife Sciences 2018; 192: 46 doi: 10.1016/j.lfs.2017.11.027
348
Rose Ghemrawi, Shyue-Fang Battaglia-Hsu, Carole Arnold. Endoplasmic Reticulum Stress in Metabolic DisordersCells 2018; 7(6): 63 doi: 10.3390/cells7060063
349
Hwa-Young Lee, Geum-Hwa Lee, Young Yoon, Han-Jung Chae. Rhus verniciflua and Eucommia ulmoides Protects Against High-Fat Diet-Induced Hepatic Steatosis by Enhancing Anti-Oxidation and AMPK ActivationThe American Journal of Chinese Medicine 2019; 47(06): 1253 doi: 10.1142/S0192415X19500642
350
Sunni Chen, Siyan Che, Shiqi Li, Zheng Ruan. The combined impact of decabromodiphenyl ether and high fat exposure on non-alcoholic fatty liver disease in vivo and in vitroToxicology 2021; 464: 153015 doi: 10.1016/j.tox.2021.153015
351
Jarosław Jerzy Sak, Andrzej Prystupa, Paweł Kiciński, Dorota Luchowska-Kocot, Ewa Kurys-Denis, Hanna Bis-Wencel. Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosisWorld Journal of Hepatology 2021; 13(12): 2071-2080 doi: 10.4254/wjh.v13.i12.2071
352
Shaaron Ochoa-Rios, Ian P. O'Connor, Lindsey N. Kent, Julian M. Clouse, Yannis Hadjiyannis, Christopher Koivisto, Thierry Pecot, Peggi M. Angel, Richard R. Drake, Gustavo Leone, Anand S. Mehta, Don C. Rockey. Imaging Mass Spectrometry Reveals Alterations in N-Linked Glycosylation That Are Associated With Histopathological Changes in Nonalcoholic Steatohepatitis in Mouse and HumanMolecular & Cellular Proteomics 2022; 21(5): 100225 doi: 10.1016/j.mcpro.2022.100225
353
Qun Liu, Shousheng Liu, Lizhen Chen, Zhenzhen Zhao, Shuixian Du, Quanjiang Dong, Yongning Xin, Shiying Xuan. Role and effective therapeutic target of gut microbiota in NAFLD/NASH (Review)Experimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.7781
354
Afshan Syed Abbas, Tasleem Akhtar, Najma Shaheen, Sumaira Aslam, Nadeem Sheikh. Mechanistic study of regulation of iron homeostasis by N. sativa seeds and P. ovata husks on high fat/high sucrose diet induced non-alcoholic fatty liver diseaseMolecular Biology Reports 2022; 49(8): 7417 doi: 10.1007/s11033-022-07538-3
355
M.S. Abdelbary, R. Marzaban, H. Gamal Eldeen, M. Khairy, M. Menesy, M.H. Fahmy, A.M. Ayad, B.S. Mouheb, A. Yosry. Clinical utility of transient elastography as an imaging tool to assess the short-term impact of laparoscopic sleeve gastrectomy, together with clinical and biochemical parameters and clinico-biochemical indices, on obese patients with nonalcoholic fatty liver disease: An Egyptian pilot studyRevista de Gastroenterología de México (English Edition) 2021; 86(2): 125 doi: 10.1016/j.rgmxen.2020.04.008
356
O. B. Nemchaninova, E. Yu. Sklyanova, S. G. Lykova, E. N. Makhnovets, O. N. Pozdnyakova, T. B. Reshetnikova, A. A. Khryanin. Comorbidity: non-alcoholic fatty liver disease and psoriasisExperimental and Clinical Gastroenterology 2021; (10): 55 doi: 10.31146/1682-8658-ecg-194-10-55-60
357
Jinsoo Song, In-Jeoung Baek, Sujeong Park, Jinjoo Oh, Deokha Kim, Kyung Song, Mi Kyung Kim, Hye Won Lee, Byoung Kuk Jang, Eun-Jung Jin. Deficiency of peroxisomal NUDT7 stimulates de novo lipogenesis in hepatocytesiScience 2022; 25(10): 105135 doi: 10.1016/j.isci.2022.105135
358
Fadl H Veerankutty, Govind Jayan, Manish Kumar Yadav, Krishnan Sarojam Manoj, Abhishek Yadav, Sindhu Radha Sadasivan Nair, T U Shabeerali, Varghese Yeldho, Madhu Sasidharan, Shiraz Ahmad Rather. Artificial Intelligence in hepatology, liver surgery and transplantation: Emerging applications and frontiers of researchWorld Journal of Hepatology 2021; 13(12): 1977-1990 doi: 10.4254/wjh.v13.i12.1977
359
Shanmugam Murugaiha Jeyakumar, Ayyalasomayajula Vajreswari. Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidenceWorld Journal of Hepatology 2022; 14(1): 168-179 doi: 10.4254/wjh.v14.i1.168
360
Sreenath Kundimi, Krishna Chaitanya Kavungala, Swaraj Sinha, Venkata Narasimha Rao Tayi, Nagendra Rao Kundurthi, Trimurtulu Golakoti, Barbara Davis, Krishanu Sengupta. Combined extracts of Moringa oleifera, Murraya koeingii leaves, and Curcuma longa rhizome increases energy expenditure and controls obesity in high-fat diet-fed ratsLipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01376-7
361
Seoung-Woo Lee, Su-Min Baek, Kyung-Ku Kang, A-Rang Lee, Tae-Un Kim, Seong-Kyoon Choi, Yoon-Seok Roh, Il-Hwa Hong, Sang-Joon Park, Tae-Hwan Kim, Kyu-Shik Jeong, Jin-Kyu Park. Vitamin C Deficiency Inhibits Nonalcoholic Fatty Liver Disease Progression through Impaired de Novo LipogenesisThe American Journal of Pathology 2021; 191(9): 1550 doi: 10.1016/j.ajpath.2021.05.020
362
Michelle L. Parker, Khosrow Adeli, Émile Lévy, Edgard Delvin. Are universal upper reference limits for alanine aminotransferase (ALT) appropriate for assessing pediatric liver injury?Clinical Biochemistry 2018; 53: 55 doi: 10.1016/j.clinbiochem.2018.01.010
363
Duanghathai Pasanta, Khin Thandar Htun, Jie Pan, Montree Tungjai, Siriprapa Kaewjaeng, Hongjoo Kim, Jakrapong Kaewkhao, Suchart Kothan. Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical ApplicationsDiagnostics 2021; 11(5): 842 doi: 10.3390/diagnostics11050842
364
Cosmas Rinaldi A. Lesmana, Maria S. Paramitha, Irsan Hasan. Comprehensive Gut Microbiota2022; : 475 doi: 10.1016/B978-0-12-819265-8.00079-6
365
Gargi Dixit, Arati Prabhu. The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeuticsExperimental and Molecular Pathology 2022; 124: 104723 doi: 10.1016/j.yexmp.2021.104723
366
Yuan Li, Shousheng Liu, Yuqiang Gao, Huan Ma, Shuhui Zhan, Yan Yang, Yongning Xin, Shiying Xuan. Association between NAFLD and Risk of Colorectal Adenoma in Chinese Han PopulationJournal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2019.00010
367
Mark A Anderson, Hamed Kordbacheh, Evita Joseph, Susan E Bennett, Fatima Cody Stanford, Avinash Kambadakone. Computed tomography findings of metabolic syndrome in patients with acute colonic diverticulitisJournal of Medical Imaging and Radiation Oncology 2021; 65(3): 279 doi: 10.1111/1754-9485.13151
368
Raja Gopal Reddy Mooli, Dhanunjay Mukhi, Sadeesh K. Ramakrishnan. Comprehensive Physiology2022; : 3167 doi: 10.1002/cphy.c200021
369
Nicolás Salva-Pastor, Mayra Domínguez-Pérez, Norberto C. Chávez-Tapia, Natalia Nuño-Lámbarri. Clinical Bioenergetics2021; : 155 doi: 10.1016/B978-0-12-819621-2.00006-1
370
Alexander L. Ticho, Pooja Malhotra, Pradeep K. Dudeja, Ravinder K. Gill, Waddah A. Alrefai. Comprehensive Physiology2019; : 21 doi: 10.1002/cphy.c190007
371
Zaki A. Sherif. Nonalcoholic Fatty Liver Disease - An Update2019;  doi: 10.5772/intechopen.85780
372
Cong Wang, Shousheng Liu, Linlin Lu, Songling Liao, Haiyan Yue, Quanjiang Dong, Yongning Xin, Shiying Xuan. Association Between Four ABCA1 gene Polymorphisms and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Han PopulationHepatitis Monthly 2018; 18(6) doi: 10.5812/hepatmon.66149
373
Hailang Li, Ling Hu, Liwen Wang, Yixuan Wang, Meiqi Shao, Yupei Chen, Wenlin Wu, Lei Wang. Iron Activates cGAS-STING Signaling and Promotes Hepatic InflammationJournal of Agricultural and Food Chemistry 2022; 70(7): 2211 doi: 10.1021/acs.jafc.1c06681